| SEC Info | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing As/For/On Docs:Pgs Issuer Agent 9/04/07 Great Atlantic & Pacific Tea..Inc S-4/A 8/31/07 8:400 Command Financi..Corp/FA
Document/Exhibit Description Pages Size
1: S-4/A Pre-Effective Amendment to Registration of HTML 2,427K
Securities Issued in a
Business-Combination Transaction
2: EX-5.1 Opinion re: Legality HTML 13K
3: EX-23.2 Consent of Experts or Counsel HTML 6K
4: EX-23.3 Consent of Experts or Counsel HTML 6K
5: EX-99.2 Miscellaneous Exhibit HTML 8K
6: EX-99.3 Miscellaneous Exhibit HTML 6K
7: EX-99.4 Miscellaneous Exhibit HTML 25K
8: EX-99.5 Miscellaneous Exhibit HTML 15K
| S-4/A | 1st "Page" of 380 | TOC | Top | Previous | Next | Bottom | Just 1st |
|---|
|
| 3B2 EDGAR HTML -- c48680_s4a.htm |
As filed with the Securities and Exchange Commission on August 31, 2007
Registration No. 333-143212
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 2
TO
FORM S-4
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
The Great Atlantic & Pacific Tea Company, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
Maryland |
5411 |
13-1890974 |
Two Paragon Drive
Montvale, New Jersey 07645
(201) 573-9700
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)
Allan Richards
Senior Vice President, Human Resources, Labor Relations, Legal Services & Secretary
The Great Atlantic & Pacific Tea Company, Inc.
Two Paragon Drive
Montvale, New Jersey 07645
(201) 573-9700
(Name, address, including zip code, and telephone number, including area code, of agent for service)
With copies to:
|
|
|
|
|
|
Kenneth W. Orce, Esq. |
Sarkis Jebejian, Esq. |
John M. Newell, Esq. |
Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after this Registration Statement is declared effective and upon completion of the merger described in the enclosed joint proxy statement/prospectus.
If the securities being registered on this form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, please check the following box. £
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. £
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. £
The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
| S-4/A | 2nd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 2nd |
|---|
PRELIMINARY—SUBJECT TO COMPLETION—DATED AUGUST 31, 2007
|
|
|
|
|
TO THE STOCKHOLDERS OF
THE GREAT ATLANTIC & PACIFIC TEA COMPANY, INC. AND
PATHMARK STORES, INC.
YOUR VOTE IS VERY IMPORTANT
On March 4, 2007, Pathmark Stores, Inc. (“Pathmark”), The Great Atlantic & Pacific Tea Company, Inc. (“A&P”) and Sand Merger Corp., a wholly owned subsidiary of A&P, entered into a merger agreement, pursuant to which A&P will acquire Pathmark and its subsidiaries through a merger. Upon completion of the merger, Pathmark stockholders will be entitled to receive, without interest, $9.00 in cash and 0.12963 shares of A&P common stock for each share of Pathmark common stock that they own. Upon completion of the merger, we estimate that Pathmark’s former stockholders will own approximately 14% of the then-outstanding common stock of A&P on a fully-diluted basis. A&P’s stockholders will continue to own their existing shares, which will not be affected by the merger.
The merger cannot be completed unless (i) Pathmark stockholders approve and adopt the merger agreement and the transactions contemplated thereby, including the merger, and (ii) A&P stockholders approve the issuance of A&P’s common stock pursuant to the merger agreement. We are each holding a special meeting of stockholders in order to obtain the stockholder approvals necessary to complete the merger. The times, dates and places of the special meetings to consider and vote upon the proposals are as follows:
|
|
|
For A&P Stockholders: |
For Pathmark Stockholders: |
After careful consideration, each of our boards of directors has determined that the merger agreement and the transactions contemplated thereby are fair to and in the best interests of our respective stockholders. Accordingly, the A&P board of directors unanimously recommends that A&P stockholders vote “FOR” the proposal to approve the issuance of shares of A&P common stock pursuant to the merger agreement and “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies. The Pathmark board of directors unanimously recommends that the Pathmark stockholders vote “FOR” the proposal to approve and adopt the merger agreement and the transactions contemplated thereby, including the merger and “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies.
The affirmative vote of a majority of the votes cast by holders of A&P common stock at the special meeting is required to approve the issuance of A&P common stock in connection with the merger, provided that the total votes cast must represent a majority of the outstanding shares of A&P common stock entitled to vote on the matter.
The affirmative vote of a majority of the outstanding shares of Pathmark common stock is required to adopt the merger agreement and approve the transactions contemplated thereby, including the merger.
The joint proxy statement/prospectus attached to this letter provides you with information about A&P, Pathmark, the proposed merger and the special meetings of each of our companies’ stockholders. In particular, please see the section titled “Risk Factors” of the accompanying joint proxy statement/prospectus which contains a description of the risks that you should consider in evaluating the proposals. You may also obtain more information about A&P and Pathmark from documents each party has filed with the Securities and Exchange Commission. Shares of A&P
| S-4/A | 3rd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 3rd |
|---|
common stock are listed on the New York Stock Exchange under the symbol “GAP.” Shares of Pathmark common stock are listed on the NASDAQ Global Market under the symbol “PTMK.”
Your vote is important. Whether or not you plan to attend your respective company’s special meeting, please take the time to vote by completing, signing and dating the enclosed proxy card and returning it in the appropriate envelope provided, or in the case of A&P stockholders, use the Internet or telephone proxy authorization options detailed on the proxy card. If your shares are held in “street name” by a bank, brokerage firm or nominee you should follow the instructions of your bank, brokerage firm or nominee, regarding the voting of your shares.
Thank you for your cooperation and continued support.
|
|
|
Allan Richards |
John T. Standley |
Neither the SEC nor any state securities commission has approved or disapproved the securities to be issued in connection with the merger or determined if the accompanying joint proxy statement/prospectus is accurate or complete. Any representation to the contrary is a criminal offense.
Information contained in this document is subject to completion or amendment. A registration statement relating to these securities has been filed with the SEC. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This joint proxy statement/prospectus shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under securities laws of such state.
THIS JOINT PROXY STATEMENT/PROSPECTUS IS DATED [ ], 2007, AND IS BEING FIRST MAILED TO STOCKHOLDERS OF A&P AND PATHMARK ON OR ABOUT [ ], 2007.
| S-4/A | 4th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 4th |
|---|

THE GREAT ATLANTIC & PACIFIC TEA COMPANY, INC.
2 Paragon Drive
Montvale, New Jersey 07645
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON [ ], 2007
To the stockholders of THE GREAT ATLANTIC & PACIFIC TEA C OMPANY, INC.:
We will hold a special meeting of stockholders of The Great Atlantic & Pacific Tea Company, Inc., a Maryland corporation (“A&P”), at The Woodcliff Lake Hilton, 200 Tice Boulevard, Woodcliff Lake, New Jersey, on [ ], [ ], 2007, at [ ] a.m., Eastern Daylight Time, for the following purposes:
|
||||||||||||||||||||
1. |
|
to consider and vote on a proposal to approve the issuance of A&P common stock pursuant to the Agreement and Plan of Merger, dated as of March 4, 2007, by and among A&P, Sand Merger Corp. (“Merger Sub”) (a wholly owned subsidiary of A&P established for the purpose of effecting the merger) and Pathmark Stores, Inc. (“Pathmark”), as amended from time to time, which provides for the merger of Merger Sub with and into Pathmark, with Pathmark as the surviving corporation; |
||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
|
2. |
|
to consider and vote on a proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies; and |
||||||||||||||||||
|
||||||||||||||||||||
|
3. |
|
to transact any other business as may properly come before the meeting and any adjournments or postponements thereof. |
||||||||||||||||||
The A&P board of directors has fixed [ ], 2007, as the record date for this meeting. Only stockholders of record at the close of business on that date are entitled to receive notice and to vote at the meeting or at any adjournment or postponement thereof.
The affirmative vote of a majority of the votes cast by holders of A&P common stock at the special meeting is required to approve Proposal 1, provided that the total votes cast must represent a majority of the outstanding shares of A&P common stock entitled to vote on the proposal. The adoption of Proposal 2 requires the affirmative vote of a majority of the votes cast by the holders of A&P common stock at the special meeting.
| S-4/A | 5th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 5th |
|---|
Whether or not you plan to attend the meeting, please either complete, sign and return the accompanying proxy card to A&P in the enclosed envelope, which requires no postage if mailed in the United States, or use the Internet or telephone proxy authorization options detailed on the proxy card. If you hold your shares through a bank, brokerage firm or nominee, you should follow the instructions of your bank, brokerage firm or nominee regarding voting your shares.
|
|
|
|
By Order of the Board of Directors |
|
|
Allan Richards |
[ ], 2007
You are cordially invited to attend the meeting. Whether or not you plan to do so, your vote is important. Please promptly submit your proxy by mail, telephone or the Internet.
| S-4/A | 6th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 6th |
|---|

PATHMARK STORES, INC.
200 MILIK STREET
CARTERET, NEW JERSEY 07008
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON [ ], 2007
To the stockholders of PATHMARK STORES, INC.:
A special meeting of stockholders of Pathmark Stores, Inc. (“Pathmark”), a Delaware corporation, will be held on [ ], 2007, at [ ] a.m., Eastern Daylight Time, at Pathmark’s corporate headquarters, 200 Milik Street, Carteret, New Jersey 07008, for the following purposes:
|
|
|
1. |
to consider and vote upon a proposal to approve and adopt the Agreement and Plan of Merger, dated March 4, 2007, by and among Pathmark, The Great Atlantic & Pacific Tea Company, Inc. (“A&P”) and Sand Merger Corp. (“Merger Sub”), and the transactions contemplated by the merger agreement, as amended from time to time, including the merger, pursuant to which Merger Sub would merge with and into Pathmark and each outstanding share of Pathmark common stock would be converted into the right to receive, without interest, $9.00 in cash and 0.12963 shares of A&P common stock; |
|
2. |
to consider and vote upon a proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies; and |
|
3. |
to consider and vote on such other matters as may properly come before the special meeting or any adjournment or postponement thereof. |
Only stockholders of record as of the close of business on [ ], 2007, are entitled to notice of and to vote at the special meeting and at any adjournment or postponement thereof. A list of these stockholders will be available for inspection by stockholders of record during regular business hours at Pathmark’s corporate headquarters, 200 Milik Street, Carteret, New Jersey 07008, for ten days prior to the date of the special meeting. All stockholders of record are cordially invited to attend the special meeting in person. Your vote is important, regardless of the number of shares of Pathmark common stock that you own.
The adoption of the merger agreement requires the approval of the holders of a majority of the outstanding shares of our common stock entitled to vote on the matter. The Pathmark board of directors unanimously recommends that the Pathmark stockholders vote “FOR” the proposal to approve and adopt the merger agreement and the transactions contemplated thereby, including the merger.
The adoption of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of a majority of shares of Pathmark common stock represented in person or by proxy at the special meeting and entitled to vote thereon. The Pathmark board of directors unanimously recommends that the Pathmark stockholders vote “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies.
Even if you plan to attend the meeting in person, we request that you complete, sign, date and return the enclosed proxy card and thus ensure that your shares will be represented at the special meeting even if you become unable to attend. If you sign, date and return your proxy card without indicating how you wish to vote, the shares represented by your proxy will be voted “FOR” the approval and adoption of the merger agreement and transactions contemplated thereby, including the merger, and “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies and will be voted in accordance with the recommendations of our board of directors on any other matters properly brought before the meeting for a vote. If you hold your shares through a bank, brokerage firm or
| S-4/A | 7th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 7th |
|---|
nominee, you should follow the instructions of your bank, brokerage firm or nominee regarding voting your shares.
Whether you attend the meeting or not, you may revoke a proxy at any time before it is voted at the meeting. You may do so by executing and returning a proxy card dated later than the previous one or by attending the special meeting and voting in person. Simply attending the meeting, however, will not revoke your proxy. If you hold your shares through a bank, brokerage firm or nominee, you should follow the instructions of your bank, brokerage firm or nominee regarding revocation of proxies. If your bank, brokerage firm or nominee allows you to submit a proxy by telephone or the Internet, you may be able to change your vote by submitting a subsequent proxy by telephone or the Internet.
|
|
|
|
|
By Order of the Board of Directors, |
|
|
|
Marc A. Strassler |
| S-4/A | 8th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 8th |
|---|
References to Additional Information
The accompanying joint proxy statement/prospectus incorporates by reference important business and financial information about A&P and Pathmark from documents that are not included in or delivered with this joint proxy statement/prospectus. This information is available to you without charge upon your written or oral request. You can obtain the documents incorporated by reference in the accompanying joint proxy statement/prospectus by requesting them in writing or by telephone from the appropriate company at the following addresses and telephone numbers:
|
|
|
The Great Atlantic & Pacific |
Pathmark Stores, Inc. |
If you would like to request documents, please do so by [ ], 2007 in order to receive them before the special meetings.
See “Where You Can Find More Information.”
About This Document
This document, which forms part of a registration statement on Form S-4 filed with the SEC by A&P, constitutes a prospectus of A&P under Section 5 of the Securities Act of 1933, as amended, and the rules thereunder, with respect to the shares of A&P common stock to be issued to the holders of Pathmark common stock in connection with the merger. This document also constitutes (i) a proxy statement under Section 14(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (ii) a notice of meeting with respect to A&P’s special meeting of stockholders, at which A&P stockholders will consider and vote upon the issuance of shares of A&P common stock to Pathmark stockholders on the terms and conditions set forth in the merger agreement; and (iii) a notice of meeting with respect to Pathmark’s special meeting of stockholders, at which Pathmark stockholders will consider and vote upon adoption of the merger agreement and the transactions contemplated thereby, including the merger.
| S-4/A | 9th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 9th |
|---|
|
|
|
|||||
|
|
Page |
||||||
|
QUESTIONS AND ANSWERS ABOUT VOTING PROCEDURES FOR THE SPECIAL MEETINGS |
|
1 |
|||||
|
5 |
|||||||
|
16 |
|||||||
|
18 |
|||||||
|
22 |
|||||||
|
23 |
|||||||
|
24 |
|||||||
|
31 |
|||||||
|
32 |
|||||||
|
35 |
|||||||
|
40 |
|||||||
|
40 |
|||||||
|
40 |
|||||||
|
40 |
|||||||
|
Pathmark’s Reasons for the Merger; Recommendation of the Pathmark Board of Directors |
63 |
||||||
|
A&P’s Reasons for the Merger; Recommendation of the A&P Board of Directors |
67 |
||||||
|
69 |
|||||||
|
77 |
|||||||
|
79 |
|||||||
|
85 |
|||||||
|
95 |
|||||||
|
98 |
|||||||
|
99 |
|||||||
|
99 |
|||||||
|
99 |
|||||||
|
Certain Material United States Federal Income Tax Consequences |
100 |
||||||
|
101 |
|||||||
|
104 |
|||||||
|
104 |
|||||||
|
104 |
|||||||
|
105 |
|||||||
|
105 |
|||||||
|
106 |
|||||||
|
106 |
|||||||
|
Treatment of Pathmark Stock Options, Warrants and Other Equity-Based Awards |
106 |
||||||
|
Exchange of Pathmark Stock Certificates for A&P Stock Certificates |
107 |
||||||
|
108 |
|||||||
|
108 |
|||||||
|
108 |
|||||||
|
108 |
|||||||
|
110 |
|||||||
|
119 |
|||||||
|
120 |
|||||||
|
122 |
|||||||
|
122 |
|||||||
|
123 |
|||||||
| S-4/A | 10th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 10th |
|---|
|
|
|
|||||
|
|
Page |
||||||
|
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION |
124 |
||||||
|
142 |
|||||||
|
164 |
|||||||
|
165 |
|||||||
|
167 |
|||||||
|
167 |
|||||||
|
171 |
|||||||
|
171 |
|||||||
|
APPROVAL OF THE ADJOURNMENT OR POSTPONEMENT OF THE PATHMARK SPECIAL MEETING (PATHMARK PROPOSAL 2) |
172 |
||||||
|
172 |
|||||||
|
APPROVAL OF THE ADJOURNMENT OR POSTPONEMENT OF THE A&P SPECIAL MEETING (A&P PROPOSAL 2) |
|
173 |
|||||
|
173 |
|||||||
|
174 |
|||||||
|
174 |
|||||||
|
174 |
|||||||
|
|
|
|
|
— |
Agreement and Plan of Merger and Amendment No. 1 to the Agreement and Plan |
|||
— |
Yucaipa Stockholder Agreement |
|||
— |
Yucaipa Voting Agreement |
|||
— |
Tengelmann Stockholder Agreement |
|||
— |
Tengelmann Voting Agreement |
|||
— |
Yucaipa Warrant Agreement |
|||
— |
Opinion of J.P. Morgan Securities Inc. |
|||
— |
Opinion of Citigroup Global Markets Inc. |
|||
|
— |
Form of Amendment to the By-Laws of The Great Atlantic & Pacific Tea |
|||
|
— |
Section 262 of the General Corporation Law of the State of Delaware
|
| S-4/A | 11th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 11th |
|---|
QUESTIONS AND ANSWERS ABOUT VOTING PROCEDURES
FOR THE SPECIAL MEETINGS
The questions and answers below highlight only selected procedural information from this document. They do not contain all of the information that may be important to you. You should read carefully the entire document and the additional documents incorporated by reference into this document because each contains important information.
|
|
|
Q: |
What are the proposals upon which I am being asked to vote? |
|
A: |
A&P Stockholders. Stockholders of The Great Atlantic & Pacific Tea Company, Inc. (“A&P”) are being asked to vote (i) to approve the issuance of shares of A&P common stock pursuant to the Agreement and Plan of Merger, dated March 4, 2007, as amended (the “merger agreement”), by and among Pathmark Stores, Inc. (“Pathmark”), A&P and Sand Merger Corp. (“Merger Sub”), under which A&P will acquire Pathmark and its subsidiaries through the merger of Merger Sub with and into Pathmark (the “merger”), and (ii) to adjourn or postpone the special meeting, if necessary, to solicit additional proxies. |
|
|
|
Pathmark Stockholders. Stockholders of Pathmark are being asked to vote (i) to approve and adopt the merger agreement and the transactions contemplated thereby, including the merger, and (ii) to adjourn or postpone the special meeting, if necessary, to solicit additional proxies. |
|
|
Q: |
What vote of Pathmark stockholders is required for adoption of the merger agreement? |
|
A: |
Adoption of the merger agreement and the transactions contemplated thereby, including the merger, requires the affirmative vote of a majority of the outstanding shares of Pathmark common stock entitled to vote. Therefore, if a Pathmark stockholder abstains or fails to vote, it will have the same effect as voting against the merger agreement. You are entitled to vote on the proposal to approve and adopt the merger agreement and the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies if you held Pathmark common stock at the close of business on the Pathmark record date, which is [ ], 2007. On that date, [ ] shares of Pathmark common stock were outstanding and entitled to vote. |
|
|
The largest stockholders of Pathmark, Yucaipa Corporate Initiatives Fund I, LP; Yucaipa American Alliance (Parallel) Fund I, LP and Yucaipa American Alliance Fund I, LP, which we refer to collectively as the “Yucaipa Investors,” have agreed to vote the shares of Pathmark common stock that they own as of the Pathmark record date in favor of adoption of the merger agreement and the transactions contemplated thereby, including the merger, provided that these voting obligations do not apply to any shares owned by the Yucaipa Investors in excess of 33% of the outstanding Pathmark common stock. The remaining shares owned by the Yucaipa Investors may be voted in the Yucaipa Investors’ discretion, although the Yucaipa Investors have expressed their present intention to vote all of the Pathmark shares they own (approximately 38% of the outstanding Pathmark common stock as of the Pathmark record date) in favor of the adoption of the merger agreement. |
|
Q: |
What vote of Pathmark stockholders is required for approval of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies? |
|
A: |
The adoption of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of a majority of shares of Pathmark common stock represented in person or by proxy at the special meeting and entitled to vote thereon. |
|
1
| S-4/A | 12th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 12th |
|---|
|
|
|
Q: |
What vote of A&P stockholders is required for approval of the proposal to issue shares of A&P common stock pursuant to the merger agreement? |
|
A: |
The proposal to issue shares of A&P common stock pursuant to the merger agreement must be approved by a majority of the votes cast by the holders of A&P common stock, provided that the total votes cast on the proposal must represent at least a majority of the outstanding shares of A&P common stock entitled to vote on the proposal. Because approval is based on the affirmative vote of a majority of votes cast, provided that the total votes cast on the proposal represent at least a majority of all shares entitled to vote on the proposal, an A&P stockholder’s failure to vote will not affect the outcome of the vote to approve the issuance of A&P common stock in connection with the merger, assuming more than a majority of the outstanding shares are voted on the proposal. Because the New York Stock Exchange (the “NYSE”) treats abstentions as votes cast with respect to the proposal to issue shares of A&P common stock pursuant to the merger agreement, an abstention will have the same effect as a vote “AGAINST” the proposal. A&P stockholders are entitled to vote on the proposal to approve the issuance of A&P common stock if they held A&P common stock at the close of business on the A&P record date, which is [ ], 2007. On the A&P record date, [ ] shares of A&P common stock were outstanding and entitled to vote. |
|
|
Tengelmann Warenhandelsgesellschaft KG (“Tengelmann”) has agreed to vote all of its shares of A&P common stock, constituting approximately 53% of the outstanding A&P common stock as of the A&P record date, in favor of the issuance of A&P common stock in the merger. This means that the approval of the issuance of the A&P common stock pursuant to the merger agreement is assured. |
|
|
Q: |
What vote of A&P stockholders is required for approval of the proposal to adjourn or postpone the meeting, if necessary, to solicit additional proxies? |
|
|
A: |
The adoption of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of a majority of the votes cast by the holders of A&P common stock at the special meeting. |
|
|
Q: |
When do you expect the merger to be completed? |
|
A: |
We expect to complete the merger after (i) the Pathmark stockholders adopt the merger agreement and the transactions contemplated thereby, including the merger, at the special meeting, (ii) the A&P stockholders approve the proposal to issue shares of A&P common stock pursuant to the merger agreement at the A&P special meeting, and (iii) we receive all necessary regulatory approvals, including the expiration or termination of the waiting period under the HSR Act, including any extension of the waiting period. We currently anticipate completing the merger in the second half of A&P’s 2007 fiscal year ending February 23, 2008. |
|
|
Q: |
If my shares are held in “street name” by a bank, brokerage firm or nominee, will they vote my shares for me? |
|
A: |
A&P Stockholders. You should instruct your bank, brokerage firm or nominee to vote your shares, following the directions they provide. If you do not instruct your bank, brokerage firm or nominee, they will generally not have the discretion to vote your shares. Because the approval of the proposal to issue A&P common stock in connection with the merger requires an affirmative vote of a majority of the votes cast by holders of A&P common stock at the special meeting, the failure to vote your shares will not affect the outcome of the vote on the proposal to approve the issuance of A&P common stock in connection with the merger, provided that the total votes cast on the proposal represent at least a majority of all shares entitled to vote on the proposal. Because the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of a majority of the votes cast by the holders of A&P common stock at the special meeting, and because brokers do not have discretionary authority to vote on the proposal, the failure to instruct your broker how to vote your shares will have no effect on the approval of that proposal. |
|
2
| S-4/A | 13th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 13th |
|---|
|
|
|
|
Pathmark Stockholders. You should instruct your bank, brokerage firm or nominee to vote your shares, following the directions they provide. If you do not instruct your bank, brokerage firm or nominee, they will generally not have the discretion to vote your shares. Because the adoption of the merger agreement requires an affirmative vote of a majority of the outstanding shares of Pathmark common stock for approval, the failure to vote your shares will have the same effect as votes cast “AGAINST” adoption of the merger agreement. Because the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of a majority of the shares of common stock present or represented at the special meeting and entitled to vote thereon, and because brokers do not have discretionary authority to vote on the proposal, the failure to instruct your broker how to vote your shares will have no effect on the approval of that proposal. |
|
Q: |
What do I need to do now? |
|
A: |
A&P Stockholders. After carefully reading and considering the information contained in this joint proxy statement/prospectus, please fill out and sign the proxy card, and then mail your signed proxy card in the enclosed prepaid envelope as soon as possible so that your shares may be voted at the A&P special meeting. Your signed proxy card will instruct the persons named on the card to vote your shares at the special meeting as you direct on the card. If you sign and send in your proxy card and do not indicate how you want your shares to be voted, your proxy will be voted “FOR” the approval of each of (1) the A&P proposal to approve the issuance of A&P common stock in connection with the merger, and (2) the A&P proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies. You may also authorize a proxy by telephone or through the Internet by following the instructions included with your proxy card. If you hold your shares through a bank, brokerage firm or nominee, you should follow the instructions of your bank, brokerage firm or nominee regarding voting your shares. YOUR VOTE IS VERY IMPORTANT. |
|
|
|
Pathmark Stockholders. After carefully reading and considering the information contained in this joint proxy statement/prospectus, please fill out and sign the proxy card, and then mail your signed proxy card in the enclosed prepaid envelope as soon as possible so that your shares may be voted at the Pathmark special meeting. Your signed proxy card will instruct the persons named on the card to vote your shares at the Pathmark special meeting as you direct on the card. If you sign and send in your proxy card and do not indicate how you want your shares to be voted, your proxy will be voted “FOR” the approval of each of (1) the Pathmark proposal to adopt the merger agreement and the transactions contemplated thereby, including the merger, and (2) the Pathmark proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies. If you hold shares through a bank, brokerage firm or nominee, you should follow the instructions of your bank, brokerage firm or nominee regarding voting your shares. YOUR VOTE IS VERY IMPORTANT. |
|
|
Q: |
May I change my vote after I have mailed my signed proxy card? |
|
A: |
You may change your vote at any time before your proxy is voted at the A&P special meeting or the Pathmark special meeting, as the case may be. You can do this in one of the following ways. First, you can send a written notice stating that you want to revoke your proxy to: |
|
|
In the case of A&P Stockholders: |
|
|
Allan Richards |
|
|
|
|
3
| S-4/A | 14th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 14th |
|---|
|
|
|
|
In the case of Pathmark Stockholders: |
|
|
Marc A. Strassler |
|
|
Second, you can complete and submit a new, later-dated proxy card. Third, you can attend the A&P special meeting or the Pathmark special meeting, as the case may be, and vote in person. Simply attending the meeting, however, will not revoke your proxy; you must vote at the meeting. Fourth, A&P stockholders, but not Pathmark stockholders, can authorize a proxy by telephone or through the Internet at a later time, but not later than 11:59 p.m. (Eastern Daylight Time) on [ ], 2007 or the day before the meeting date if the special meeting is adjourned or postponed. |
|
|
|
If you have instructed a broker to vote your shares, you must follow directions received from your broker to change your vote. |
|
Q: |
Should I send in my Pathmark or A&P stock certificates now? |
|
|
A: |
No. After the merger is completed, Pathmark stockholders will receive written instructions for exchanging their stock certificates. |
|
|
A&P stockholders will continue to hold their A&P stock certificates following the merger and are not required to take any action with respect to their A&P stock certificates. |
|
Q: |
Who can help answer my questions? |
|
A: |
A&P Stockholders. If you have any questions about the A&P special meeting or if you need additional copies of this joint proxy statement/prospectus or the enclosed proxy card, please contact: |
|
|
Investor Relations |
|
|
or: |
|
|
|
Mackenzie Partners, Inc. |
|
|
|
Pathmark Stockholders. If you have any questions about the Pathmark special meeting or if you need additional copies of this joint proxy statement/prospectus or the enclosed proxy card, please contact: |
|
|
Investor Relations |
|
|
or: |
|
|
|
Mellon Investor Services LLC
|
|
4
| S-4/A | 15th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 15th |
|---|
The following summary highlights selected information from this joint proxy statement/ prospectus and may not contain all of the information that may be important to you. Accordingly, stockholders are encouraged to carefully read this entire joint proxy statement/prospectus, its annexes and the documents referred to or incorporated by reference into this joint proxy statement/prospectus. Each item in this summary includes a page reference directing you to a more complete description of that item.
The Merger (Page 40)
On March 4, 2007, A&P, Merger Sub, a newly formed, wholly owned subsidiary of A&P, and Pathmark entered into the merger agreement, pursuant to which A&P will acquire Pathmark and its subsidiaries through the merger of Merger Sub with and into Pathmark. After the merger, Pathmark will be the surviving corporation and a wholly owned subsidiary of A&P. Shares of A&P common stock received by Pathmark stockholders in the merger will be listed on the NYSE under the symbol “GAP.” After completion of the merger, shares of A&P common stock will continue to be traded on the NYSE, but shares of Pathmark common stock will no longer be publicly listed or traded. Upon completion of the merger, approximately 86% of A&P common stock will be held by existing A&P stockholders and approximately 14% will be held by former Pathmark stockholders on a fully diluted basis.
Merger Consideration (Page 106)
Pathmark Common Stock
Pursuant to the merger, each share of Pathmark common stock will be converted into the right to receive (i) 0.12963, which we refer to as the “exchange ratio,” of a share of A&P common stock and (ii) $9.00 in cash, which we refer to as the “per share cash consideration,” without interest. No fractional shares of A&P common stock will be issued in connection with the merger; holders of Pathmark common stock will receive cash in lieu of any fractional shares of A&P common stock they otherwise would have received in the merger.
The exchange ratio is a fixed ratio, which means that it will not change between now and the time the merger is completed. Therefore, the market value of the A&P common stock received by Pathmark stockholders in the merger will depend on the market price of A&P common stock at the time the merger is completed.
For example, a Pathmark stockholder owning 1,000 shares of Pathmark common stock would receive total consideration of $9,000.00 in cash and 129 shares of A&P common stock, plus a cash payment, in lieu of the fractional interest of 0.63 shares of A&P common stock that would otherwise be receivable, determined by multiplying (i) the number of fractional shares of A&P common stock otherwise receivable by such holder, or 0.63 shares in this example, by (ii) the closing price of the A&P common stock on the NYSE on the trading day immediately prior to the closing date.
Treatment of Pathmark Stock Options, Warrants and Equity-Based Awards
Outstanding Pathmark stock options granted under Pathmark stock compensation plans will become fully vested and exercisable no less than fifteen days prior to the closing date of the merger. Outstanding Pathmark stock options at the closing date of the merger and granted under Pathmark stock compensation plans, other than certain options described in the next paragraph, will be canceled. Any stock options with exercise prices less than the per share closing price of Pathmark common stock on the last trading day immediately prior to the closing date will entitle their holders to receive a lump sum cash payment to be paid as soon as practicable after the completion of the merger, in an amount based on the Pathmark closing price, as described in more detail under “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger Agreement—Treatment of Pathmark Stock Options, Warrants and Other Equity-Based Awards.” Any stock options with
5
| S-4/A | 16th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 16th |
|---|
exercise prices equal to or greater than the Pathmark closing price will be canceled for no consideration.
With respect to Pathmark stock options that were granted under Pathmark stock plans prior to June 9, 2005, Pathmark has agreed to use commercially reasonable efforts to obtain consents to cancel any such options with exercise prices less than the Pathmark closing price on the last trading day immediately prior to the closing date in exchange for a lump sum cash payment as described in the previous paragraph. Any such Pathmark stock options not canceled and cashed out, or with exercise prices equal to or greater than the Pathmark closing price, will be converted into an option to purchase, on the same terms and conditions, a number of shares of A&P common stock and at an exercise price determined as described under “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger Agreement—Treatment of Pathmark Stock Options, Warrants and Other Equity-Based Awards.”
Outstanding awards of Pathmark restricted stock units or restricted stock will become fully vested and will be converted into the right to receive a lump sum cash payment equal to the product of (a) the number of shares of Pathmark common stock subject to the award immediately prior to the closing and (b) the closing price of Pathmark common stock on the last trading day before the closing date, as described in more detail under “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger Agreement—Treatment of Pathmark Stock Options, Warrants and Other Equity- Based Awards.”
The Yucaipa Investors’ existing Series A and Series B Warrants to purchase Pathmark common stock will be exchanged for warrants to purchase A&P common stock. See “Adoption of the Merger Agreement (Pathmark Proposal 1)—Yucaipa Warrant Agreement.”
A&P will assume the obligations of Pathmark under the Warrant Agreement dated as of September 19, 2000 between Pathmark and ChaseMellon Shareholder Services, LLC (the “2000 Warrant Agreement”), and the warrants issued thereunder, so that the holders of the assumed warrants will have the right to purchase A&P common stock on the terms and subject to the conditions set forth in the 2000 Warrant Agreement and the warrants thereunder.
Recommendations of the Boards of Directors
A&P (page 67). The A&P board of directors has determined that entering into the merger agreement is advisable and in the best interests of A&P and has unanimously approved the merger agreement and the transactions it contemplates, recommended that its stockholders approve the issuance of A&P common stock pursuant to the merger agreement, and declared entering into the merger agreement advisable. For the factors considered by the A&P board of directors in reaching its decision to approve, and declare the advisability of entering into, the merger agreement and the transactions it contemplates, see “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—A&P’s Reasons for the Merger; Recommendation of the A&P Board of Directors.” The A&P board of directors unanimously recommends that the A&P stockholders vote “FOR” the proposal to approve the issuance of shares of A&P common stock pursuant to the merger agreement, and “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies.
Pathmark (page 63). The Pathmark board of directors has determined that the merger is fair to and in the best interests of Pathmark and its stockholders and has unanimously approved the merger agreement and the transactions it contemplates, including the merger, and has declared the merger agreement advisable. For the factors considered by the Pathmark board of directors in reaching its decision to approve, and declare the advisability of entering into, the merger agreement and the transactions it contemplates, see “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Pathmark’s Reasons for the Merger; Recommendation of the Pathmark Board of Directors.” The Pathmark board of directors unanimously recommends that the Pathmark stockholders vote “FOR” the proposal to approve and adopt the merger agreement and the transactions contemplated thereby, including the merger, and “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies.
6
| S-4/A | 17th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 17th |
|---|
Opinions of Financial Advisors
A&P (page 79). In deciding to approve the merger and advise that A&P stockholders approve the share issuance, the A&P board of directors considered the opinion of its financial advisor, J.P. Morgan Securities Inc., which we refer to as “JPMorgan,” provided to the A&P board of directors on March 4, 2007, that as of the date of the opinion, and based on and subject to the qualifications, assumptions and limitations set forth therein, the merger consideration to be paid by A&P was fair, from a financial point of view, to A&P. A copy of the opinion of JPMorgan is attached to this document as Annex G. A&P stockholders should read the opinion completely and carefully to understand, among other things, the assumptions made, procedures followed, matters considered and limits on the review undertaken by JPMorgan in providing its opinion. Additionally, A&P agreed to pay JPMorgan a transaction fee in connection with the merger, a significant portion of which is payable upon completion of the merger. The JPMorgan opinion is not a recommendation as to how any stockholder of A&P should vote with respect to the A&P share issuance or any other matter.
Pathmark (page 69). In deciding to approve the merger and advise that Pathmark stockholders approve and adopt the merger agreement, the Pathmark board of directors considered the opinion of its financial advisor, Citigroup Global Markets Inc., which we refer to as “Citigroup,” provided to the Pathmark board of directors on March 4, 2007, that as of the date of the written opinion and based upon and subject to the considerations and limitations set forth in its written opinion, its work described in the written opinion and other factors it deemed relevant, the merger consideration was fair, from a financial point of view, to the holders of Pathmark common stock (other than the Yucaipa Group, as defined below). A copy of the opinion of Citigroup is attached to this document as Annex H. Pathmark stockholders should read the opinion completely and carefully to understand, among other things, the assumptions made, procedures followed, matters considered and limits on the review undertaken by Citigroup in providing its opinion. Additionally, Pathmark agreed to pay Citigroup a transaction fee in connection with the merger, a significant portion of which is payable upon completion of the merger. The Citigroup opinion is not a recommendation as to how any stockholder should vote with respect to the proposal to approve and adopt the merger agreement or any other matter.
Interests of Certain Persons in the Merger (Page 85)
Some of the members of A&P’s and Pathmark’s management, certain members of their boards of directors and certain of their significant stockholders have interests in the merger that are different from, or in addition to, the interests of A&P and Pathmark stockholders generally.
These interests include the right of certain of Pathmark’s executive officers to receive severance payments and benefits under the terms of existing severance agreements and the acceleration of vesting of Pathmark stock options and other equity-based awards as a result of the merger.
The Yucaipa Companies LLC (“Yucaipa Companies”), an affiliate of the Yucaipa Investors, will receive a fee in connection with termination of the Management Services Agreement dated March 23, 2005 with Pathmark (the “Management Services Agreement”) and Yucaipa Advisors, LLC (“Yucaipa Advisors”), also an affiliate of the Yucaipa Investors, will receive a transaction fee for services rendered in connection with the merger. In addition, warrants to purchase Pathmark common stock owned by the Yucaipa Investors will be converted into warrants to purchase A&P common stock and the Yucaipa Investors will receive certain registration rights for A&P shares acquired by the Yucaipa Investors in connection with the merger and those issuable upon conversion of the Yucaipa Investors’ warrants.
In addition, subject to certain conditions, in connection with the merger, Gregory Mays, a director of Pathmark, will be elected by the existing A&P directors to fill the existing vacant position on the A&P board of directors without stockholder action, as provided for under the director election provisions in accordance with the bylaws of A&P and Maryland law.
The Pathmark board of directors was aware of these interests and considered them, among other matters, in approving and declaring the advisability of the merger agreement.
7
| S-4/A | 18th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 18th |
|---|
The largest stockholder of A&P, Tengelmann, has entered into a stockholder agreement with A&P whereby Tengelmann will have certain approval, registration, preemptive and other rights after the merger as described in more detail under “Adoption of the Merger Agreement (Pathmark Proposal 1)—Tengelmann Stockholder Agreement.” Tengelmann and A&P have also agreed to negotiate in good faith to enter into a services agreement for services rendered by Tengelmann to A&P from time to time in exchange for reasonable compensation as agreed by Tengelmann and A&P.
The A&P board of directors was aware of these interests and considered them, among other matters, in approving and declaring the advisability of the merger agreement and the A&P share issuance.
Directors and Officers Following Completion of the Merger (Page 108)
Following the merger, Christian Haub, Executive Chairman of A&P, will continue as Executive Chairman of A&P; Eric Claus, President and CEO of A&P, will also maintain those same positions at A&P. Four directors who were serving on A&P’s board immediately prior to the closing of the merger and were not designated for nomination by Tengelmann will continue in their current positions and four directors will be designated for nomination to A&P’s board by Tengelmann. Gregory Mays, a director of Pathmark, will be elected to the A&P board of directors by the existing A&P directors, subject to certain conditions, as provided for under the bylaws of A&P and Maryland law.
Financing (Page 95)
A&P estimates that the total amount of funds necessary to pay the cash portion of the merger consideration will be approximately $485.5 million. A&P expects that this amount will be provided through a combination of (i) $190.0 million of net cash proceeds from the sale of 6,350,000 of its shares of Metro, Inc. (“Metro”) common stock, which A&P received in connection with the August 2005 sale of its Canadian operations to Metro, a Canadian supermarket and pharmacy operator, and (ii) up to $780.0 million in senior secured notes (or, if the offering of senior secured notes is not completed on or prior to the closing of the merger, up to $780.0 million under a senior secured bridge credit facility). On March 13, 2007, A&P sold 6,350,000 shares of its holdings in Metro for net cash proceeds of approximately $203.5 million. A&P continues to hold approximately 11.7 million Metro shares. The merger is not conditioned on receipt of financing by A&P. Bank of America, N.A. (“Bank of America”), Banc of America Bridge LLC (“Banc of America Bridge”), Banc of America Securities LLC (“BAS”), Lehman Brothers Commercial Bank (“LBCB”), Lehman Brothers Inc. (“Lehman”) and Lehman Commercial Paper Inc. (“LCPI”) have entered into a commitment letter with A&P whereby (i) Bank of America has committed to provide a $615.0 million senior secured revolving credit facility (the “ABL Facility”) to finance the working capital of A&P and certain of its subsidiaries (including Pathmark) upon consummation of the merger and (ii) Banc of America Bridge and LBCB have severally committed to provide in the aggregate up to $780.0 million of senior secured loans (the “Bridge Facility” and together with the ABL Facility, the “Facilities”) as “bridge” or interim financing to senior secured notes which may be issued by A&P and/or certain of its subsidiaries for the purpose of refinancing advances made under the Bridge Facility.
Governmental and Regulatory Approvals (Page 98)
Under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder, which we refer to as the “HSR Act,” the merger may not be consummated unless a waiting period has expired or been terminated and there can be no assurances that such expiration or termination will be obtained. A&P and Pathmark filed the required notification and report forms with the Antitrust Division of the Department of Justice and the Federal Trade Commission regarding the merger on March 19, 2007. On April 18, 2007, A&P and Pathmark each received a request for additional information and documentary materials, which we refer to as the “Second Request,” from the Federal Trade Commission. As a result of the Second
8
| S-4/A | 19th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 19th |
|---|
Request, A&P cannot complete the merger under the HSR Act until the earlier of (i) 30 days after both parties substantially comply with the Second Request (or on the next regular business day if the 30th day falls on a Saturday, Sunday or legal public holiday), unless that waiting period is extended by agreement between A&P and the Federal Trade Commission, or (ii) when the Federal Trade Commission terminates its review of the merger. On May 21, 2007, A&P announced that it had entered into a timing agreement with the Federal Trade Commission, pursuant to which A&P agreed, subject to certain conditions, to not (i) certify that they have substantially complied with the Second Request prior to June 30, 2007, or (ii) consummate the merger for at least 60 days following the date that A&P and Pathmark substantially comply with the Second Request. On July 13, 2007, A&P and Pathmark each certified substantial compliance with the Federal Trade Commission in response to the Second Request. On August 7, 2007, A&P and Pathmark entered into an extension of the timing agreement with the Federal Trade Commission pursuant to which A&P and Pathmark agreed, subject to certain conditions, that they will not consummate A&P’s acquisition of Pathmark before 11:59 p.m. on September 25, 2007.
Conditions to the Merger (Page 119)
The obligations of A&P and Pathmark to complete the merger are subject to the satisfaction or waiver of a number of conditions, including:
|
||||||||||||||||||||
| ||||||||||||||||||||
• |
|
the receipt of the required approval of Pathmark stockholders to adopt the merger agreement and the required approvals of A&P stockholders to approve the issuance of A&P common stock in the merger and an amendment to A&P’s charter to exempt the transactions contemplated by the merger agreement and the agreements entered into in connection therewith from the preemptive rights provisions of the A&P charter. (At A&P’s annual meeting of stockholders on July 19, 2007, A&P stockholders approved an amendment to eliminate such provisions from A&P’s charter.); |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
the expiration or termination of the waiting period applicable to the merger under the HSR Act, including any extension of the waiting period; |
||||||||||||||||||
| ||||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
the approval for listing of the shares of A&P common stock to be issued in connection with the merger on the NYSE; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
the continued effectiveness of the registration statement on Form S-4, of which this joint proxy statement/prospectus forms a part; and |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
other customary conditions set forth in the merger agreement, including the accuracy of representations and warranties set forth in the merger agreement; the performance of obligations under the merger agreement; and the absence of orders, injunctions or other legal restraints or prohibitions preventing completion of the merger. |
||||||||||||||||||
In addition, A&P’s obligation to complete the merger is subject to the conditions that the aggregate number of shares of Pathmark stock held by Pathmark stockholders who are entitled to demand, and who properly demand, an appraisal of such holders’ shares in accordance with Section 262 of the General Corporation Law of the State of Delaware, which we refer to as the “DGCL” (and who comply in all other respects with Section 262), does not exceed 10% of the shares of Pathmark common stock outstanding immediately prior to the completion of the merger; that there be no pending or threatened legal action or similar proceeding seeking to restrain or prohibit the merger, impose certain limitations on implementing the merger or which has had or would reasonably be expected to have a material adverse effect with respect to Pathmark; that no material adverse effect has occurred or would reasonably be expected to occur with respect to Pathmark; and that the Management Services Agreement and related consulting agreement have been terminated pursuant to their terms.
Restrictions on Solicitation of Other Offers (Page 113)
Subject to certain exceptions, the merger agreement restricts Pathmark, its subsidiaries and their respective directors, officers and other representatives from soliciting or knowingly encouraging or facilitating third-party proposals to acquire Pathmark or from entering into, initiating or participating
9
| S-4/A | 20th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 20th |
|---|
in any discussions or negotiations, furnishing any nonpublic information or assisting or knowingly encouraging any third party with respect to such proposals. Under certain circumstances, however, if Pathmark receives an unsolicited acquisition proposal from a third party, Pathmark may furnish nonpublic information to, and engage in negotiations with, that third party, subject to specified conditions.
Termination of the Merger Agreement (Page 120)
A&P and Pathmark may terminate the merger agreement without completing the merger by agreement in writing at any time, even after the Pathmark stockholders have voted to adopt the merger agreement and the A&P stockholders have approved the issuance of A&P common stock and the A&P charter amendment. The merger agreement may also be terminated at any time prior to the effective time of the merger in other specified circumstances, including:
|
||||||||||||||||||||
• |
|
by either A&P or Pathmark if: |
||||||||||||||||||
|
||||||||||||||||||||
| • |
|
the merger is not completed by the outside date of March 4, 2008 (the “Outside Date”), which date may be extended once for a period up to ninety days under certain circumstances; |
||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
|
• |
|
Pathmark stockholders fail to adopt the merger agreement at the Pathmark special meeting or A&P stockholders fail to approve both the issuance of A&P common stock in the merger and the A&P charter amendment at the A&P special meeting. (At A&P’s annual meeting of stockholders on July 19, 2007, A&P stockholders approved an amendment to eliminate such provisions from A&P’s charter.); |
||||||||||||||||||
| ||||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
a governmental entity issues an order, injunction or other legal restraint or prohibition preventing completion of the merger; or |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
the other party breaches or fails to perform any representation, warranty, covenant or agreement in the merger agreement which breach or failure to perform would cause the failure of a closing condition which is not curable or is not cured following notice; or |
||||||||||||||||||
|
||||||||||||||||||||
• |
|
by A&P if: |
||||||||||||||||||
|
||||||||||||||||||||
| • |
|
prior to the Pathmark special meeting, the Pathmark board of directors withdraws, modifies or qualifies in a manner adverse to A&P its recommendation of the merger; or |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
on September 4, 2007 or on December 4, 2007, the A&P board of directors elects to terminate the merger agreement based on its good faith determination that completing the merger would be reasonably likely to require divesting stores, businesses or other assets of A&P and Pathmark in excess of an aggregate of $36.0 million of scheduled store level cashflow, subject to requirements to discuss the determination with Pathmark and to pay certain fees and expenses, if applicable, as described under “—Termination fees and expenses”; or |
||||||||||||||||||
|
||||||||||||||||||||
• |
|
by Pathmark if: |
||||||||||||||||||
|
||||||||||||||||||||
| • |
|
A&P fails to obtain $190.0 million of net cash proceeds by June 2, 2007 from the sale of Metro common stock or A&P common stock and/or preferred stock (on March 13, 2007, A&P sold 6,350,000 shares of its holdings in Metro for proceeds of approximately $203.5 million) or such amount fails to remain unencumbered and held separately to pay the merger consideration; or |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
the marketing period provided under the merger agreement to arrange the debt financing for the merger has expired, the conditions to the completion of the merger have been satisfied or waived and A&P does not have available funds to pay the aggregate cash consideration payable in the merger. |
||||||||||||||||||
Termination Fees and Expenses (Page 122)
Pathmark will pay A&P a termination fee of $25.0 million in connection with the termination of the merger agreement in certain circumstances involving a competing acquisition proposal by a third
10
| S-4/A | 21st "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 21st |
|---|
party or a change in the Pathmark board of directors’ recommendation of the merger to Pathmark’s stockholders.
In addition, A&P has agreed to pay Pathmark termination fees under the following circumstances:
|
||||||||||||||||||||
• |
|
a $25.0 million termination fee, referred to as the “Nine-Month Termination Fee,” if (i) A&P terminates the merger agreement on December 4, 2007 because A&P has determined in good faith, subject to certain requirements, that required divestitures would be reasonably likely to exceed $36.0 million of aggregate scheduled store level cashflow or (ii) A&P or Pathmark terminates the merger agreement after September 4, 2007 and on or before December 4, 2007 because any court or other governmental entity has restrained or prohibited completion of the merger at the request of any person seeking relief under antitrust laws; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
a $50.0 million termination fee, referred to as the “One-Year Termination Fee,” if (i) March 4, 2008 has been reached and (a) the Outside Date for completing the merger has not been extended, (b) the antitrust-related conditions to closing the merger have not been satisfied and (c) A&P or Pathmark terminates the merger agreement because of failure to complete the merger by the Outside Date or (ii) A&P or Pathmark terminates the merger agreement after December 4, 2007 and on or before March 4, 2008 because any court or other governmental entity has restrained or prohibited completion of the merger at the request of any person seeking relief under antitrust laws; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
a $75.0 million termination fee, referred to as the “Extension Termination Fee,” if (i) the Outside Date for completing the merger has been extended and A&P or Pathmark terminates the merger agreement because of failure to complete the merger by the extended Outside Date or (ii) A&P or Pathmark terminates the merger agreement after March 4, 2008 because any court or other governmental entity has restrained or prohibited completion of the merger at the request of any person seeking relief under antitrust laws; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
a $50.0 million termination fee if Pathmark terminates the merger agreement because of A&P’s failure to obtain $190.0 million of net cash proceeds by June 2, 2007 from the sale of Metro common stock or A&P common stock and/or preferred stock (on March 13, 2007, A&P sold 6,350,000 shares of its holdings in Metro for proceeds of approximately $203.5 million) or because such amount fails to remain unencumbered and held separately to pay the merger consideration; and |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
a $50.0 million termination fee if Pathmark terminates the merger agreement on or prior to March 4, 2008 (or $75.0 million if so terminated after March 4, 2008) because (i) A&P does not have available funds to pay the aggregate cash consideration payable in the merger, (ii) the marketing period provided under the merger agreement to arrange the debt financing for the merger has expired and (iii) the conditions to the completion of the merger have been satisfied or waived. |
||||||||||||||||||
If A&P or Pathmark terminates the merger agreement because of the failure of the Pathmark stockholders to adopt the merger agreement at the Pathmark special meeting, then Pathmark must pay A&P all filing fees paid by A&P under the HSR Act as well as legal fees and expenses incurred by A&P in connection with the merger agreement and the transactions contemplated thereby. This payment of fees and expenses will reduce the amount of any termination fees to be paid by Pathmark.
If A&P or Pathmark terminates the merger agreement because of the failure of the A&P stockholders to approve both the issuance of the A&P common stock pursuant to the merger agreement and the A&P charter amendment at the A&P special meeting or if A&P terminates the merger agreement on September 4, 2007, pursuant A&P’s right to terminate the merger agreement under certain circumstances if A&P determines that it is reasonably likely that divestitures required to meet antitrust requirements would exceed $36.0 million of aggregate scheduled store level cashflow, then A&P must pay Pathmark the legal fees and expenses incurred by Pathmark in connection with the merger agreement and the transactions contemplated thereby. (At A&P’s annual
11
| S-4/A | 22nd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 22nd |
|---|
meeting of stockholders on July 19, 2007, A&P stockholders approved an amendment to eliminate such provisions from A&P’s charter.)
Certain Material United States Federal Income Tax Consequences (Page 100)
The receipt of the merger consideration, or cash pursuant to the exercise of dissenters’ rights, by Pathmark stockholders in exchange for Pathmark common stock will be a taxable transaction for United States federal income tax purposes.
You should read “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Certain Material United States Federal Income Tax Consequences” for a more complete discussion of the United States federal income tax consequences of the merger. Tax matters are complicated and the tax consequences of the merger to you will depend on the facts of your particular situation. Because individual circumstances may differ, we urge you to consult with your tax advisor as to the specific tax consequences of the merger to you, including the applicability of United States federal, state, local, foreign and other tax laws.
Comparison of Stockholders’ Rights (Page 142)
As a result of the merger, the holders of Pathmark common stock will become holders of A&P common stock. Following the merger, Pathmark stockholders will have different rights as stockholders of A&P than as stockholders of Pathmark due to differences between the laws of the states of incorporation and the different provisions of the governing documents of A&P and Pathmark. See “Adoption of the Merger Agreement (Pathmark Proposal 1)—Comparison of Stockholders’ Rights.”
Comparative Stock Prices and Dividends (Page 23)
Shares of A&P common stock are listed on the NYSE under the symbol “GAP.” Shares of Pathmark common stock are listed on the NASDAQ Global Market (“NASDAQ”) under the symbol “PTMK.” The following table presents the last reported sale prices of A&P common stock and Pathmark common stock, as reported on:
|
||||||||||||||||||||
• |
|
February 26, 2007, the last full trading day before both A&P and Pathmark issued press releases regarding a potential business combination involving the companies; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
March 2, 2007, the last full trading day prior to the public announcement of the merger agreement; and |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
[ ], 2007, the last full trading day prior to the printing date of this proxy statement/prospectus. |
||||||||||||||||||
The table also presents the equivalent value of the merger consideration per share of Pathmark common stock on those dates.
|
|
|
|
|
|
|
|||||||||||||||
|
|
A&P |
Pathmark |
Equivalent Price Per |
||||||||||||||||||
|
$ |
|
30.87 |
|
$ |
|
12.05 |
|
$ |
|
13.00 |
||||||||||
|
$ |
|
30.86 |
|
$ |
|
11.25 |
|
$ |
|
13.00 |
||||||||||
|
[ ], 2007 |
|
$ |
|
[ ] |
|
$ |
|
[ ] |
|
$ |
|
[ ] |
|||||||||
|
||||||||||||||||||||
(1) |
|
Calculated by adding (i) the cash portion of the merger consideration, or $9.00, and (ii) the A&P closing per share stock price on February 26, 2007, March 2, 2007 or [ ], 2007 (as the case may be) multiplied by 0.12963. |
||||||||||||||||||
Trading prices of A&P and Pathmark common stock and, consequently, the value of the merger consideration will fluctuate prior to the closing date of the merger, and A&P and Pathmark stockholders are urged to obtain current market quotations prior to making any decision with respect to how such stockholders will vote regarding the merger or the A&P share issuance proposal, as the case may be.
Although A&P declared and paid a special one-time dividend to its stockholders of record on April 17, 2006 equal to $7.25 per share in April 2006, A&P’s policy is to not pay dividends. As such, A&P has not paid any dividends, other than the special one-time dividend paid in 2006, during the
12
| S-4/A | 23rd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 23rd |
|---|
previous four years and does not intend to pay dividends in the normal course of business in fiscal 2007. A&P is permitted, however, under the terms of its credit agreements, to pay cash dividends on shares of common stock.
Pathmark did not pay any cash dividends to its stockholders during fiscal 2006 and does not currently anticipate paying cash dividends during fiscal 2007. Pathmark is prohibited from paying cash dividends to holders of Pathmark common stock under the terms of its amended and restated $250 million senior secured credit facility dated as of October 1, 2004, as amended, with a group of lenders led by Fleet Retail Group. In addition, Pathmark is restricted from paying cash dividends to holders of Pathmark common stock under the indenture governing its $350 million 8.75% Senior Subordinated Notes, due 2012.
Appraisal Rights (Page 101)
Under Delaware law, if the merger is completed, Pathmark stockholders of record who demand an appraisal of their shares, do not vote in favor of the merger and properly perfect their appraisal rights pursuant to, and in accordance with, Section 262 of the DGCL (and do not subsequently lose or withdraw such rights) will be entitled to receive payment in cash for the judicially determined fair value of their shares of Pathmark common stock plus a fair rate of interest, if any, on the amount determined to be the fair value of the shares. The relevant provisions of the DGCL relating to the rights of Pathmark stockholders to such appraisal are included as Annex J to this joint proxy statement/prospectus.
The A&P Special Meeting (Page 32)
The A&P special meeting will be held at The Woodcliff Lake Hilton, 200 Tice Boulevard, Woodcliff Lake, New Jersey, on [ ], [ ], 2007, at 9:00 a.m., Eastern Daylight Time, for the following purposes:
|
||||||||||||||||||||
| • |
|
to consider and vote on a proposal to approve the issuance of A&P common stock pursuant to the merger agreement; |
||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
|
• |
|
to consider and vote on a proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies; and |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
to transact any other business that may properly be brought before the A&P special meeting and any adjournments or postponements thereof. |
||||||||||||||||||
| ||||||||||||||||||||
Only record holders of A&P common stock at the close of business on [ ], 2007 will be entitled to vote at the A&P special meeting. Each share of A&P common stock is entitled to one vote for each matter presented at the meeting. As of the record date of [ ], 2007, there were [ ] shares of A&P common stock entitled to vote at the A&P special meeting.
The stock issuance proposal requires the affirmative vote of a majority of all votes cast by the holders of common stock at a meeting, provided that the total votes cast represent at least a majority of the outstanding shares entitled to vote on the proposal. Because approval is based on the affirmative vote of a majority of votes cast, an A&P stockholder’s failure to vote will not affect the outcome of the vote to approve the issuance of A&P common stock in connection with the merger, assuming the total votes cast on the proposal represent at least a majority of all shares entitled to vote on the proposal. Because the NYSE treats abstentions as votes cast with respect to the proposal to issue shares of A&P common stock pursuant to the merger agreement, an abstention will have the same effect as a vote “AGAINST” this proposal. Abstentions will be counted for the purposes of determining whether a quorum exists at the A&P special meeting.
The proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of a majority of the votes cast by the holders of A&P common stock at the special meeting. Therefore, an A&P stockholder’s failure to vote or an abstention will have no effect on the outcome of the vote on such proposal.
As of the A&P record date, directors and executive officers of A&P and their affiliates had the right to vote [ ] shares of A&P common stock, or [ ]% of the outstanding A&P common stock entitled to be voted at the A&P special meeting.
13
| S-4/A | 24th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 24th |
|---|
Tengelmann has agreed to vote all of its shares of A&P common stock, approximately 53% of the outstanding A&P common stock as of the A&P record date, in favor of the issuance of A&P common stock in the merger. This means that the approval of the issuance of the A&P common stock pursuant to the merger agreement is assured.
The Pathmark Special Meeting (Page 35)
The Pathmark special meeting will be held at Pathmark’s corporate headquarters, 200 Milik Street, Carteret, New Jersey 07008, on [ ], [ ], 2007, at [ ] a.m., Eastern Daylight Time, for the following purposes:
|
||||||||||||||||||||
• |
|
to consider and vote upon a proposal to adopt the merger agreement and the transactions contemplated thereby, including the merger; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
to consider and vote upon a proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies; and |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
to consider and vote on such other matters as may properly be brought before the Pathmark special meeting and any adjournments or postponements thereof. |
||||||||||||||||||
Only record holders of Pathmark common stock at the close of business on [ ], 2007 will be entitled to vote at the Pathmark special meeting. Each share of Pathmark common stock is entitled to one vote for each matter presented at the meeting. As of the record date of [ ], 2007, there were [ ] shares of Pathmark common stock entitled to vote at the Pathmark special meeting.
The proposal to adopt the merger agreement and the transactions contemplated thereby, including the merger, requires an affirmative vote of the holders of a majority of the outstanding shares of Pathmark common stock entitled to vote at the Pathmark special meeting. A Pathmark stockholder’s failure to vote or an abstention will have the same effect as a vote “AGAINST” the proposal to adopt the merger agreement and the transactions contemplated thereby, including the merger, because approval is based on the affirmative vote of a majority of shares outstanding and entitled to vote. The proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of the holders of a majority of the shares of common stock present or represented at the special meeting and entitled to vote thereon. Accordingly, an abstention on the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies will have the same effect as a vote “AGAINST” that proposal, but the failure to attend the meeting and vote in person, to submit a proxy, or to provide voting instructions to your bank, brokerage firm or nominee will have no effect on the outcome of the proposal.
As of the Pathmark record date, directors and executive officers of Pathmark had the right to vote [ ] shares of Pathmark common stock, or [ ]% of the outstanding Pathmark common stock entitled to be voted at the Pathmark special meeting.
The Yucaipa Investors have agreed to vote shares of Pathmark common stock that they own as of the Pathmark record date in favor of adoption of the merger agreement and the transactions contemplated thereby, including the merger, provided that these voting obligations do not apply to any other shares owned by the Yucaipa Investors in excess of 33% of the outstanding Pathmark common stock. The remaining shares owned by the Yucaipa Investors may be voted in the Yucaipa Investors’ discretion, although the Yucaipa Investors have expressed their present intention to vote all of the Pathmark shares they own (approximately 38% of the outstanding Pathmark common stock as of the Pathmark record date) in favor of the adoption of the merger agreement.
Information about the companies
A&P
The address and telephone number of the executive offices are:
Two Paragon Drive
Montvale, New Jersey 07645
(201) 573-9700
14
| S-4/A | 25th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 25th |
|---|
A&P is a Maryland corporation and is engaged in the retail food business. A&P operated over 400 stores averaging over 40,000 square feet per store as of February 24, 2007.
Operating under the trade names A&P, Super Fresh, Sav-A-Center, Farmer Jack, Waldbaum’s, Super Foodmart, Food Basics and The Food Emporium, A&P sells groceries, meats, fresh produce and other items commonly offered in supermarkets. In addition, many stores have bakery, delicatessen, pharmacy, floral, fresh fish and cheese departments and on-site banking. National, regional and local brands are sold, as well as private label merchandise. In support of A&P’s retail operations, A&P sells other private-label products in its stores under other brand names of A&P which include, without limitation, America’s Choice, Master Choice, Health Pride and Savings Plus.
Merger Sub
The address and telephone number of the executive offices are:
Two Paragon Drive
Montvale, New Jersey 07645
(201) 573-9700
Merger Sub is a Delaware corporation and a wholly owned subsidiary of A&P. Merger Sub was organized on February 22, 2007 solely for the purpose of effecting the merger with Pathmark. It has not carried on any activities other than in connection with the merger agreement.
Pathmark
The address and telephone number of the executive offices are:
200 Milik Street
Carteret, New Jersey 07008
(732) 499-3000
Pathmark is a Delaware corporation and is a leading supermarket chain in the densely populated New York-New Jersey and Philadelphia metropolitan areas, operating as a single segment with 141 stores. All of its stores are located within 100 miles of its corporate office in Carteret, New Jersey, and of its company-operated and outsourced distribution facilities. Pathmark was incorporated in Delaware in 1987 and is the successor by merger to a business established in 1966.
15
| S-4/A | 26th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 26th |
|---|
SELECTED HISTORICAL FINANCIAL AND OTHER DATA OF A&P
The following table sets forth selected historical consolidated financial information and other data of A&P for the periods presented. The selected financial information as of February 22, 2003, February 28, 2004, February 26, 2005, February 25, 2006 and February 24, 2007, and for each of the five fiscal years then ended, has been derived from A&P’s consolidated financial statements audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm. The selected historical financial and other data of A&P for the first quarters ended June 16, 2007 and June 17, 2006 presented below has been derived from A&P’s unaudited consolidated financial statements, which, in the opinion of management, reflect all adjustments, consisting of only normal, recurring adjustments, necessary for a fair presentation of such data and which have been prepared in accordance with the same accounting principles followed in the presentation of the A&P audited financial statements for the year ended February 24, 2007. The operating results for the quarter ended June 16, 2007 are not necessarily indicative for the results that may be expected for the fiscal year. This financial information and other data should be read in conjunction with the audited and unaudited consolidated financial statements of A&P, including the notes thereto, incorporated in this joint proxy statement/prospectus by reference. See “Where You Can Find More Information.”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
Fiscal Quarter Ended |
Fiscal Year Ended |
|||||||||||||||||||||||||||||||||||||||||||||||
|
February 24, |
February 25, |
||||||||||||||||||||||||||||||||||||||||||||||||
|
|
(In millions, except per share and “Other” amounts) |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Operating Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Sales |
$ |
|
1,986.9 |
|
$ |
|
1,994.4 |
|
$ |
|
6,437.7 |
|
$ |
|
8,345.9 |
|
$ |
|
10,456.1 |
|
$ |
|
10,518.9 |
|
$ |
|
9,701.1 |
||||||||||||||||||||||
|
(Loss) income from operations |
(114.2 |
) |
|
|
(10.8 |
) |
|
|
(40.0 |
) |
|
|
(306.2 |
) |
|
|
(63.8 |
) |
|
|
(133.4 |
) |
|
|
23.5 |
||||||||||||||||||||||||
|
Depreciation and amortization |
56.3 |
|
54.9 |
|
(167.7 |
) |
|
|
(196.2 |
) |
|
|
(255.7 |
) |
|
|
(263.1 |
) |
|
|
(238.9 |
) |
|
||||||||||||||||||||||||||
|
(Loss) gain on sale of Canadian operations |
(0.3 |
) |
|
|
(0.3 |
) |
|
|
1.3 |
|
912.1 |
|
— |
|
— |
|
— |
||||||||||||||||||||||||||||||||
|
Interest expense(c) |
(21.4 |
) |
|
|
(21.3 |
) |
|
|
(71.3 |
) |
|
|
(89.7 |
) |
|
|
(112.0 |
) |
|
|
(101.8 |
) |
|
|
(98.6 |
) |
|
||||||||||||||||||||||
|
Income (loss) from continuing operations |
(26.1 |
) |
|
|
(8.6 |
) |
|
|
4.0 |
|
404.8 |
|
(172.7 |
) |
|
|
(202.4 |
) |
|
|
(197.8 |
) |
|
||||||||||||||||||||||||||
|
Income (loss) from discontinued operations |
(17.0 |
) |
|
|
2.5 |
|
22.9 |
|
(12.2 |
) |
|
|
(15.4 |
) |
|
|
(53.5 |
) |
|
|
3.2 |
||||||||||||||||||||||||||||
|
Income (loss) before cumulative effect of change in accounting principle |
(43.1 |
) |
|
|
(6.1 |
) |
|
|
26.9 |
|
392.6 |
|
(188.1 |
) |
|
|
(148.9 |
) |
|
|
(194.6 |
) |
|
||||||||||||||||||||||||||
|
Cumulative effect of a change in accounting principle— |
— |
|
— |
|
— |
|
— |
|
— |
|
(8.0 |
) |
|
|
— |
||||||||||||||||||||||||||||||||||
|
Net income (loss) |
(43.1 |
) |
|
|
(6.1 |
) |
|
|
26.9 |
|
392.6 |
|
(188.1 |
) |
|
|
(156.9 |
) |
|
|
(194.6 |
) |
|
||||||||||||||||||||||||||
|
Per Share Data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations—basic |
(0.62 |
) |
|
|
(0.21 |
) |
|
|
0.10 |
|
10.04 |
|
(4.48 |
) |
|
|
(5.26 |
) |
|
|
(5.13 |
) |
|
||||||||||||||||||||||||||
|
Income (loss) from discontinued operations—basic |
(0.41 |
) |
|
|
(0.06 |
) |
|
|
0.55 |
|
(0.30 |
) |
|
|
(0.40 |
) |
|
|
1.39 |
|
0.08 |
||||||||||||||||||||||||||||
|
Cumulative effect of a change in accounting principle— |
— |
|
— |
|
— |
|
— |
|
— |
|
(0.21 |
) |
|
|
— |
||||||||||||||||||||||||||||||||||
|
Net income (loss)—basic |
(1.03 |
) |
|
|
(0.15 |
) |
|
|
0.65 |
|
9.74 |
|
(4.88 |
) |
|
|
(4.08 |
) |
|
|
(5.05 |
) |
|
||||||||||||||||||||||||||
|
Income (loss) from continuing operations—diluted |
(0.62 |
) |
|
|
(0.21 |
) |
|
|
0.10 |
|
9.94 |
|
(4.48 |
) |
|
|
(5.26 |
) |
|
|
(5.13 |
) |
|
||||||||||||||||||||||||||
|
Income (loss) from discontinued operations—diluted |
(0.41 |
) |
|
|
(0.06 |
) |
|
|
0.54 |
|
(0.30 |
) |
|
|
(0.40 |
) |
|
|
1.39 |
|
0.08 |
||||||||||||||||||||||||||||
|
Cumulative effect of a change in accounting principle— |
— |
|
— |
|
— |
|
— |
|
— |
|
(0.21 |
) |
|
|
— |
||||||||||||||||||||||||||||||||||
|
Net income (loss)—diluted |
(1.03 |
) |
|
|
(0.15 |
) |
|
|
0.64 |
|
9.64 |
|
(4.88 |
) |
|
|
(4.08 |
) |
|
|
(5.05 |
) |
|
||||||||||||||||||||||||||
|
Cash dividends(e) |
— |
|
— |
|
7.25 |
|
— |
|
— |
|
— |
|
— |
||||||||||||||||||||||||||||||||||||
|
Book value per share(e) |
13.35 |
|
9.30 |
|
10.36 |
|
16.32 |
|
6.03 |
|
10.20 |
|
13.39 |
||||||||||||||||||||||||||||||||||||
See notes to selected financial data.
16
| S-4/A | 27th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 27th |
|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
Fiscal Quarter Ended |
Fiscal Year Ended |
|||||||||||||||||||||||||||||||||||||||||||||||
|
February 24, |
February 25, |
||||||||||||||||||||||||||||||||||||||||||||||||
|
|
(In millions, except per share and “Other” amounts) |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Financial Position |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Current assets |
$ |
|
949.3 |
|
$ |
|
880.7 |
|
$ |
|
748.9 |
|
$ |
|
1,210.0 |
|
$ |
|
1,164.7 |
|
$ |
|
1,199.0 |
|
$ |
|
1,121.4 |
||||||||||||||||||||||
|
Current liabilities |
513.7 |
|
584.9 |
|
558.4 |
|
610.3 |
|
1,078.2 |
|
1,083.2 |
|
1,090.6 |
||||||||||||||||||||||||||||||||||||
|
Working capital(e) |
430.6 |
|
295.7 |
|
190.5 |
|
599.7 |
|
86.5 |
|
115.7 |
|
30.8 |
||||||||||||||||||||||||||||||||||||
|
Current ratio(e) |
1.94 |
|
1.51 |
|
1.34 |
|
1.98 |
|
1.08 |
|
1.11 |
|
1.03 |
||||||||||||||||||||||||||||||||||||
|
Expenditures for property |
(50.9 |
) |
|
|
(68.1 |
) |
|
|
208.2 |
|
191.1 |
|
216.1 |
|
161.0 |
|
242.4 |
||||||||||||||||||||||||||||||||
|
Total assets |
2,307.8 |
|
2,196.4 |
|
2,111.6 |
|
2,498.9 |
|
2,802.0 |
|
2,902.9 |
|
2,996.3 |
||||||||||||||||||||||||||||||||||||
|
Current portion of long-term debt(f) |
0.0 |
|
32.4 |
|
32.1 |
|
0.6 |
|
2.3 |
|
2.3 |
|
25.8 |
||||||||||||||||||||||||||||||||||||
|
Current portion of capital lease obligations |
1.6 |
|
2.0 |
|
1.6 |
|
2.3 |
|
8.3 |
|
15.9 |
|
13.8 |
||||||||||||||||||||||||||||||||||||
|
Long-term debt(c) |
254.2 |
|
284.8 |
|
284.2 |
|
246.3 |
|
634.0 |
|
642.3 |
|
803.3 |
||||||||||||||||||||||||||||||||||||
|
Long-term portion of capital lease obligations |
29.5 |
|
31.8 |
|
29.9 |
|
32.3 |
|
52.2 |
|
55.2 |
|
66.1 |
||||||||||||||||||||||||||||||||||||
|
Total debt |
285.3 |
|
351.0 |
|
347.8 |
|
281.4 |
|
696.8 |
|
715.7 |
|
909.0 |
||||||||||||||||||||||||||||||||||||
|
Debt to total capitalization(i) |
34 |
% |
|
|
48 |
% |
|
|
45 |
% |
|
|
30 |
% |
|
|
75 |
% |
|
|
65 |
% |
|
|
64 |
% |
|
||||||||||||||||||||||
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Stockholders’ equity(g) |
559.5 |
|
385.9 |
|
430.7 |
|
671.7 |
|
233.8 |
|
392.8 |
|
515.7 |
||||||||||||||||||||||||||||||||||||
|
Weighted average shares outstanding—basic |
41,801.4 |
|
41,280.6 |
|
41,430.6 |
|
40,301.1 |
|
38,558.6 |
|
38,516.8 |
|
38,494.8 |
||||||||||||||||||||||||||||||||||||
|
Weighted average shares outstanding—diluted |
42,259.8 |
|
41,839.3 |
|
41,902.3 |
|
40,725.9 |
|
38,558.6 |
|
38,516.8 |
|
38,494.8 |
||||||||||||||||||||||||||||||||||||
|
Number of registered stockholders(e)(h) |
4,698 |
|
4,479 |
|
4,649 |
|
4,916 |
|
5,289 |
|
5,469 |
|
5,751 |
||||||||||||||||||||||||||||||||||||
|
Other(e) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Number of employees |
[ ] |
|
[ ] |
|
38,000 |
|
38,000 |
|
73,000 |
|
74,185 |
|
78,710 |
||||||||||||||||||||||||||||||||||||
|
New store openings |
2 |
|
1 |
|
10 |
|
3 |
|
24 |
|
19 |
|
31 |
||||||||||||||||||||||||||||||||||||
|
Number of stores at year end |
403 |
|
405 |
|
406 |
|
405 |
|
647 |
|
633 |
|
695 |
||||||||||||||||||||||||||||||||||||
|
Total store area (square feet) |
16,466,870 |
|
16,494,793 |
|
16,538,410 |
|
16,508,969 |
|
25,583,138 |
|
24,724,168 |
|
26,817,650 |
||||||||||||||||||||||||||||||||||||
|
Number of franchised stores served at year end |
— |
|
— |
|
— |
|
— |
|
42 |
|
63 |
|
65 |
||||||||||||||||||||||||||||||||||||
|
Total franchised store area (square feet) |
— |
|
— |
|
— |
|
— |
|
1,375,611 |
|
2,048,016 |
|
2,066,401 |
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||
(a) |
|
At the close of business on August 13, 2005, A&P completed the sale of its Canadian business to Metro. |
||||||||||||||||||
|
||||||||||||||||||||
|
(b) |
|
On February 27, 2005 the first day of A&P’s 2005 fiscal year, A&P adopted the Financial Accounting Standards Board Statement of Financial Accounting Standards (“SFAS”) No. 123(R) and recorded share-based compensation expense of $8.2 million and $9.0 million in fiscal 2006 and fiscal 2005, respectively. |
||||||||||||||||||
|
||||||||||||||||||||
|
(c) |
|
In fiscal 2005, A&P repurchased the majority of its 7.75% Notes due April 15, 2007 and its 9.125% Senior Notes due December 15, 2011. |
||||||||||||||||||
|
||||||||||||||||||||
|
(d) |
|
In fiscal 2003, the Financial Accounting Standards Board (“FASB”) issued revised interpretation No. 46, “Consolidation of Variable Interest Entities—an interpretation of ‘Accounting Research Bulletin No. 51.’ ” As of February 23, 2003, A&P adopted its guidance as A&P was deemed the primary beneficiary and included the franchise operations in A&P’s consolidated financial statements for fiscal 2003, fiscal 2004 and fiscal 2005. |
||||||||||||||||||
|
||||||||||||||||||||
|
(e) |
|
Not derived from audited financial information. |
||||||||||||||||||
|
||||||||||||||||||||
|
(f) |
|
In April 2007, A&P’s 7.75% Notes become due and payable in full. |
||||||||||||||||||
|
||||||||||||||||||||
|
(g) |
|
On April 25, 2006, A&P paid a special one-time dividend to its stockholders of record on April 17, 2006 equal to $7.25 per share. This dividend payout totaling $299.1 million was recorded as a reduction of “Additional paid in capital” in A&P’s Consolidated Balance Sheets at February 24, 2007. |
||||||||||||||||||
|
||||||||||||||||||||
|
(h) |
|
Actual number, not millions. |
||||||||||||||||||
|
||||||||||||||||||||
|
(i) |
|
Calculated as total debt divided by the sum of total debt and stockholders’ equity. |
||||||||||||||||||
17
| S-4/A | 28th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 28th |
|---|
SELECTED HISTORICAL FINANCIAL AND OTHER DATA OF PATHMARK
The following table sets forth selected historical consolidated financial information and other data of Pathmark for the periods presented. The selected consolidated statements of income data for the fiscal years ended February 3, 2007, January 28, 2006 and January 29, 2005 and the selected consolidated balance sheet data as of February 3, 2007 and January 28, 2006 have been derived from Pathmark’s audited consolidated financial statements, incorporated by reference in this joint proxy statement/prospectus. The selected consolidated statements of income data for the fiscal years ended January 31, 2004 and February 1, 2003 and the selected consolidated balance sheet data as of January 29, 2005, January 31, 2004 and February 1, 2003 are derived from audited consolidated financial statements not included or incorporated by reference in this joint proxy statement/prospectus. The selected historical financial and other data of Pathmark for the first quarters ended May 5, 2007 and April 29, 2006 presented below was derived from Pathmark’s unaudited consolidated financial statements, which, in the opinion of management, reflect all adjustments, consisting of only normal, recurring adjustments, necessary for a fair presentation of such data and which have been prepared in accordance with the same accounting principles followed in the presentation of Pathmark’s audited financial statements for the year ended February 3, 2007. The operating results for the quarter ended May 5, 2007 is not necessarily indicative for the results that may be expected for the fiscal year. This consolidated financial information and other data should be read in conjunction with the audited and unaudited consolidated financial statements of Pathmark, including the notes thereto, incorporated in this joint proxy statement/prospectus by reference. See “Where You Can Find More Information.”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
Fiscal Quarter |
Fiscal Year |
|||||||||||||||||||||||||||||||||||||||||||||||
|
13 Weeks |
13 Weeks |
53 Weeks |
52 Weeks |
52 Weeks |
52 Weeks |
52 Weeks |
|||||||||||||||||||||||||||||||||||||||||||
|
|
(In millions, except per share amounts) |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Operating Results: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Sales |
|
$ |
|
999.0 |
|
$ |
|
998.5 |
|
$ |
|
4058.0 |
|
$ |
|
3977.0 |
|
$ |
|
3978.5 |
|
$ |
|
3,991.3 |
|
$ |
|
3,937.7 |
|||||||||||||||||||||
|
Cost of goods sold |
(702.7 |
) |
|
|
(709.0 |
) |
|
|
(2,875.2 |
) |
|
|
(2,846.3 |
) |
|
|
(2,846.1 |
) |
|
|
(2,852.6 |
) |
|
|
(2,816.7 |
) |
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Gross profit |
296.3 |
|
289.5 |
|
1,182.8 |
|
1,130.7 |
|
1,132.4 |
|
1,138.7 |
|
1,121.0 |
||||||||||||||||||||||||||||||||||||
|
Selling, general and administrative expenses(a) |
|
267.3 |
|
(259.8 |
) |
|
|
(1,056.8 |
) |
|
|
(1,040.9 |
) |
|
|
(984.9 |
) |
|
|
(953.9 |
) |
|
|
(944.4 |
) |
|
|||||||||||||||||||||||
|
Depreciation and amortization(b) |
(23.5 |
) |
|
|
(23.0 |
) |
|
|
(92.6 |
) |
|
|
(90.8 |
) |
|
|
(89.4 |
) |
|
|
(84.0 |
) |
|
|
(84.6 |
) |
|
||||||||||||||||||||||
|
Impairment of goodwill and long-lived assets(c) |
— |
|
— |
|
— |
|
— |
|
(309.0 |
) |
|
|
— |
|
— |
||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Operating earnings (loss) |
5.5 |
|
6.7 |
|
33.4 |
|
(1.0 |
) |
|
|
(250.9 |
) |
|
|
100.8 |
|
92.0 |
||||||||||||||||||||||||||||||||
|
Interest expense, net(d) |
(15.9 |
) |
|
|
(15.5 |
) |
|
|
(62.3 |
) |
|
|
(64.7 |
) |
|
|
(67.0 |
) |
|
|
(72.5 |
) |
|
|
(65.1 |
) |
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Earnings (loss) before income taxes and cumulative effect of an accounting change |
(10.4 |
) |
|
|
(8.8 |
) |
|
|
(28.9 |
) |
|
|
(65.7 |
) |
|
|
(317.9 |
) |
|
|
28.3 |
|
26.9 |
||||||||||||||||||||||||||
|
Income tax benefit (provision) |
1.9 |
|
3.4 |
|
10.6 |
|
25.6 |
|
9.3 |
|
(11.8 |
) |
|
|
(13.0 |
) |
|
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Earnings (loss) before cumulative effect of an accounting change |
(8.5 |
) |
|
|
(5.4 |
) |
|
|
(18.3 |
) |
|
|
(40.1 |
) |
|
|
(308.6 |
) |
|
|
16.5 |
|
13.9 |
||||||||||||||||||||||||||
|
Cumulative effect of an accounting change, net of tax(e) |
— |
|
— |
|
— |
|
— |
|
— |
|
— |
|
(0.6 |
) |
|
||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Net earnings (loss) |
$ |
|
(8.5 |
) |
|
|
$ |
|
(5.4 |
) |
|
|
$ |
|
(18.3 |
) |
|
|
$ |
|
(40.1 |
) |
|
|
$ |
|
(308.6 |
) |
|
|
$ |
|
16.5 |
|
$ |
|
13.3 |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Weighted-average number of shares outstanding—basic |
52.3 |
|
52.0 |
|
52.1 |
|
43.5 |
|
30.1 |
|
30.1 |
|
30.1 |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Weighted-average number of shares outstanding—diluted |
52.3 |
|
52.0 |
|
52.1 |
|
43.5 |
|
30.1 |
|
30.4 |
|
30.4 |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Net earnings (loss) per share—basic |
(0.16 |
) |
|
|
(0.10 |
) |
|
|
$ |
|
(0.35 |
) |
|
|
$ |
|
(0.92 |
) |
|
|
$ |
|
(10.26 |
) |
|
|
$ |
|
0.55 |
|
$ |
|
0.44 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Net earnings (loss) per share—diluted |
(0.16 |
) |
|
|
(0.10 |
) |
|
|
$ |
|
(0.35 |
) |
|
|
$ |
|
(0.92 |
) |
|
|
$ |
|
(10.26 |
) |
|
|
$ |
|
0.54 |
|
$ |
|
0.44 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Same-store sales increase (decrease) |
(0.3 |
)% |
|
|
(0.1 |
)% |
|
|
0.4 |
% |
|
|
(0.8 |
)% |
|
|
(0.8 |
)% |
|
|
1.2 |
% |
|
|
(1.7 |
)% |
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Capital expenditures, including property acquired under capital leases and technology investments |
$ |
|
14.7 |
|
$ |
|
12.1 |
|
$ |
|
71.8 |
|
$ |
|
64.5 |
|
$ |
|
119.0 |
|
$ |
|
79.3 |
|
$ |
|
121.1 |
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
See notes to selected historical financial and other data of Pathmark.
18
| S-4/A | 29th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 29th |
|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
At |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Financial Position: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
Total assets(f) |
$ |
|
1,128.8 |
|
$ |
|
1,240.8 |
|
$ |
|
1,132.4 |
|
$ |
|
1,254.6 |
|
$ |
|
1,253.4 |
|
$ |
|
1,520.9 |
|
$ |
|
1,522.6 |
||||||||||||||||||||||
|
Cash, cash equivalents and marketable securities |
31.8 |
|
68.0 |
|
28.1 |
|
77.4 |
|
42.6 |
|
8.9 |
|
11.3 |
||||||||||||||||||||||||||||||||||||
|
Debt (excluding capital lease obligations) |
446.2 |
|
424.9 |
|
448.2 |
|
425.9 |
|
481.2 |
|
428.4 |
|
451.7 |
||||||||||||||||||||||||||||||||||||
|
Capital lease obligations |
167.5 |
|
176.4 |
|
169.8 |
|
179.6 |
|
193.4 |
|
196.5 |
|
201.2 |
||||||||||||||||||||||||||||||||||||
|
Total debt, including capital lease obligations |
613.7 |
|
601.3 |
|
618.0 |
|
605.5 |
|
674.6 |
|
624.9 |
|
652.9 |
||||||||||||||||||||||||||||||||||||
|
Stockholders’ equity(f) |
118.0 |
|
168.0 |
|
128.4 |
|
171.3 |
|
65.2 |
|
375.0 |
|
356.8 |
||||||||||||||||||||||||||||||||||||
See notes to selected historical financial and other data of Pathmark.
19
| S-4/A | 30th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 30th |
|---|
Notes to Selected Historical Financial and Other Data of Pathmark
|
||||||||||||||||||||
| ||||||||||||||||||||
(a) |
|
Selling, general and administrative expenses (“SG&A”) in the first quarter ended May 5, 2007 included a $4.2 million charge for early retirement and benefits-related expenses related to a voluntary retirement incentive program Pathmark offered to certain of its store associates covered by collective bargaining agreements (“Store Labor Buyout”) in which 152 store associates accepted the Store Labor Buyout and agreed to retire no later than May 5, 2007. SG&A in fiscal 2006 included a $9.7 million non-cash charge related to stock-based compensation in accordance with SFAS No. 123(R), “Share-Based Payment” and $2.9 million in expenses related to the proposed merger with A&P, partially offset by gift card breakage income of $3.5 million. SG&A in fiscal 2005 included a $14.6 million charge related to employee-related separation costs, comprised of (i) an $8.4 million charge related to a corporate headcount reduction program, (ii) a $3.6 million charge related to a store labor buyout initiative, and (iii) a $2.6 million charge related to separation agreements with two former executives. In addition, SG&A in fiscal 2005 included a $4.7 million charge related to the merchandising and store initiative. SG&A in fiscal 2004 is net of a $1.4 million credit to correct, on a cumulative basis, the accounting related to straight-line rent expense and long-term disability and a $1.5 million gain from the sale of real estate. Fiscal 2003 included a $13.7 million gain from the sale of real estate related to the assignment of two real estate leases and an $8.1 million charge related to a store labor buyout initiative and a corporate headcount reduction program. Fiscal 2002 included a $2.0 million charge related to a store labor buyout program. |
||||||||||||||||||
| ||||||||||||||||||||
|
||||||||||||||||||||
|
(b) |
|
Depreciation and amortization in fiscal 2004 included a charge of $2.0 million to correct, on a cumulative basis, the amortization of certain leasehold improvements. |
||||||||||||||||||
|
||||||||||||||||||||
|
(c) |
|
In accordance with SFAS No. 142, “Goodwill and Other Intangible Assets,” Pathmark’s goodwill balance is evaluated for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired. Based on an evaluation of its fair value in fiscal 2002, fiscal 2003, fiscal 2005 and fiscal 2006, Pathmark concluded that there was no impairment of its goodwill. Based on Pathmark’s evaluation of its goodwill and long-lived assets performed in fiscal 2004, Pathmark recorded a non-cash impairment charge of $309.0 million. The goodwill impairment of $293.8 million, which is not deductible for income tax purposes, represented the write-down of the carrying value of Pathmark’s goodwill to its implied fair value and was due to Pathmark’s declining operating performance in fiscal 2004 and the reduced valuation multiples in the retail grocery industry, which were reflected in Pathmark’s stock price and market capitalization. The long-lived assets’ impairment of $15.2 million represents the write-down of under-performing stores to their fair market values. |
||||||||||||||||||
|
||||||||||||||||||||
|
(d) |
|
Interest expense in fiscal 2005 included a charge of $2.8 million as a result of the defeasance of Pathmark’s mortgage borrowings utilizing a portion of the proceeds of certain purchased securities. Fiscal 2004 included a write-off of deferred financing costs of $1.7 million related to the refinancing and pay down of Pathmark’s previous credit agreement. Fiscal 2003 included a derivative settlement charge of $3.7 million related to the termination and settlement of Pathmark’s $150 million interest rate zero-cost collar and the writeoff of deferred financing costs of $2.1 million as a result of the repayment of $153 million of Pathmark’s term loan primarily from proceeds from the issuance of an additional $150 million ($100 million on September 19, 2003 and $50 million on December 18, 2003) aggregate principal amount of Senior Subordinated Notes. Fiscal 2002 included the reversal of an accrued interest liability of $2.2 million related to the favorable resolution of certain tax issues. |
||||||||||||||||||
|
||||||||||||||||||||
|
(e) |
|
In fiscal 2002, Pathmark adopted Emerging Issues Task Force (“EITF”) Issue No. 02-16, “Accounting by a Customer (Including a Reseller) for Certain Consideration Received from a Vendor.” In adopting EITF Issue No. 02-16, vendor payments related to advertising reimbursements are recorded as a reduction of cost of goods sold when both the required advertising is performed and the inventory is sold; prior to this change, these reimbursements were recorded as a reduction of advertising expense when the required advertising was |
||||||||||||||||||
20
| S-4/A | 31st "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 31st |
|---|
performed. As a result, Pathmark recorded a charge in fiscal 2002 of $0.6 million, net of an income tax benefit of $0.4 million, for the cumulative effect of an accounting change. |
||||||||||||||||||||
|
||||||||||||||||||||
|
(f) |
|
In fiscal 2006, Pathmark adopted SFAS No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans—an amendment of SFAS Nos. 87, 88, 106 and 132(R).” As a result, Pathmark recognized the funded status of its defined benefit postretirement plans as an asset or a liability, with changes resulting from adoption reducing stockholders’ equity by $36.0 million as of February 3, 2007. SFAS No. 158 did not change the existing criteria for measurement of periodic benefit costs, plan assets or benefit obligations. |
||||||||||||||||||
21
| S-4/A | 32nd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 32nd |
|---|
The following table sets forth certain historical, pro forma combined and pro forma-equivalent per share financial information for A&P common stock and Pathmark common stock. The pro forma and pro forma-equivalent per share information gives effect to the merger as if the merger had been effective on February 24, 2007 and June 16, 2007 (as the case may be), in the case of the book value data presented, and as if the merger had become effective at the beginning of the fiscal year ended February 24, 2007 and the end of the fiscal quarter ended June 16, 2007 (as the case may be), in the case of the net income and dividends declared data presented.
The following information should be read in conjunction with the audited consolidated financial statements of A&P and Pathmark, which are incorporated by reference into this joint proxy statement/prospectus, and the unaudited pro forma condensed combined financial data beginning on page 124. The pro forma information below assumes that the merger will be accounted for using the purchase method of accounting, represents a current estimate based on available information and is subject to change as additional information becomes available. It is presented for informational purposes only and is not necessarily indicative of the operating results or financial position that would have occurred if the merger had been completed as of the beginning of the periods presented, nor is it necessarily indicative of the future operating results or financial position of the combined company.
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Fiscal Year Ended |
A&P |
Pathmark |
Unaudited |
Unaudited |
|
|||||||||||||||||||||||||
|
Diluted per common share: |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net (loss) income per share |
$ |
|
0.64 |
|
$ |
|
(0.35 |
) |
|
|
$ |
|
(2.09 |
) |
|
|
$ |
|
(0.27 |
) |
|
|
||||||||
|
Dividends declared per common share |
|
$ |
|
7.25 |
|
$ |
|
— |
|
$ |
|
— |
|
$ |
|
— |
|
|||||||||||||
|
Book value per share at period end |
|
$ |
|
10.36 |
|
$ |
|
2.46 |
|
|
|
n/a |
|
|
|
n/a |
|
|||||||||||||
|
||||||||||||||||||||
(1) |
|
Pathmark information is presented as of and for the period ended February 3, 2007. |
||||||||||||||||||
|
||||||||||||||||||||
|
(2) |
|
Pathmark equivalent per share amounts are calculated by multiplying pro forma amounts by the exchange ratio of 0.12963. |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Fiscal Quarter Ended |
A&P |
Pathmark |
Unaudited |
Unaudited |
|
|||||||||||||||||||||||||
|
Diluted per common share: |
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Net (loss) income per share |
|
$ |
|
(1.03 |
) |
|
|
$ |
|
(0.16 |
) |
|
|
$ |
|
0.43 |
|
|
|
$ |
|
0.06 |
|
|
|
|||||
|
Dividends declared per common share |
|
$ |
|
— |
|
$ |
|
— |
|
$ |
|
— |
|
$ |
|
— |
|
|||||||||||||
|
Book value per share at period end |
|
$ |
|
13.35 |
|
$ |
|
2.25 |
|
$ |
|
14.26 |
|
$ |
|
1.85 |
|
|||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
(1) |
|
Pathmark information is presented as of and for the period ended May 5, 2007. |
||||||||||||||||||
|
||||||||||||||||||||
|
(2) |
|
Pathmark equivalent per share amounts are calculated by multiplying pro forma amounts by the exchange ratio of 0.12963. |
||||||||||||||||||
| ||||||||||||||||||||
22
| S-4/A | 33rd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 33rd |
|---|
COMPARATIVE STOCK PRICES AND DIVIDENDS
A&P common stock is listed and traded on the NYSE under the symbol “GAP.” Pathmark common stock is listed and traded on NASDAQ under the symbol “PTMK.” The following table sets forth, for the calendar quarters indicated, the high and low sales prices per share of A&P common stock and Pathmark common stock. The table also sets forth the cash dividends per share declared by A&P and Pathmark with respect to its common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
|
A&P Common Stock |
Pathmark Common Stock |
||||||||||||||||||||||||||||||||||||||||
High |
Low |
Dividends |
High |
Low |
Dividends |
|||||||||||||||||||||||||||||||||||||
|
Calendar Quarters |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
First Quarter |
|
$ |
|
15.50 |
|
$ |
|
8.09 |
|
— |
|
$ |
|
6.74 |
|
$ |
|
4.43 |
|
— |
||||||||||||||||||||||
|
Second Quarter |
|
$ |
|
29.70 |
|
$ |
|
14.57 |
|
— |
|
$ |
|
9.52 |
|
$ |
|
5.94 |
|
— |
||||||||||||||||||||||
|
Third Quarter |
|
$ |
|
35.20 |
|
$ |
|
23.80 |
|
— |
|
$ |
|
12.30 |
|
$ |
|
8.63 |
|
— |
||||||||||||||||||||||
|
Fourth Quarter |
|
$ |
|
32.30 |
|
$ |
|
24.89 |
|
— |
|
$ |
|
11.38 |
|
$ |
|
8.65 |
|
— |
||||||||||||||||||||||
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
First Quarter |
|
$ |
|
35.90 |
|
$ |
|
28.04 |
|
— |
|
$ |
|
11.54 |
|
$ |
|
9.59 |
|
— |
||||||||||||||||||||||
|
Second Quarter |
|
$ |
|
37.02 |
|
$ |
|
20.93 |
|
$ |
|
7.25 |
|
$ |
|
11.48 |
|
$ |
|
8.43 |
|
— |
||||||||||||||||||||
|
Third Quarter |
|
$ |
|
24.54 |
|
$ |
|
20.67 |
|
— |
|
$ |
|
10.49 |
|
$ |
|
7.60 |
|
— |
||||||||||||||||||||||
|
Fourth Quarter |
|
$ |
|
28.64 |
|
$ |
|
23.95 |
|
— |
|
$ |
|
11.43 |
|
$ |
|
9.75 |
|
— |
||||||||||||||||||||||
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
First Quarter |
|
$ |
|
34.39 |
|
$ |
|
25.27 |
|
— |
|
$ |
|
12.89 |
|
$ |
|
10.70 |
|
— |
||||||||||||||||||||||
|
Second Quarter |
|
$ |
|
35.70 |
|
$ |
|
29.81 |
|
— |
|
$ |
|
13.18 |
|
$ |
|
12.21 |
|
— |
||||||||||||||||||||||
|
Third Quarter* |
|
$ |
|
35.77 |
|
$ |
|
29.15 |
|
— |
|
$ |
|
13.22 |
|
$ |
|
12.38 |
|
— |
||||||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
* |
|
Through August 28, 2007 |
||||||||||||||||||
| ||||||||||||||||||||
On February 26, 2007, the last trading day before A&P and Pathmark issued press releases regarding a potential business combination involving the companies, the last sale price of Pathmark common stock was $12.05 per share and the last sale price of A&P common stock was $30.87 per share. On March 2, 2007, the last trading day prior to the announcement of the execution of the merger agreement, the last sale price of Pathmark common stock was $11.25 per share and the last sale price of A&P common stock was $30.86 per share. On [ ], 2007, the most recent practicable trading day prior to the printing of this joint proxy statement/prospectus, the last sale price of Pathmark common stock was $[ ] per share and the last sale price of A&P common stock was $[ ] per share. The market prices of shares of Pathmark common stock and A&P common stock are subject to fluctuation. As a result, Pathmark stockholders are urged to obtain current market quotations. On [ ], 2007, the record date for the Pathmark special meeting, there were approximately [ ] shares of Pathmark common stock outstanding. On [ ], the record date for the A&P special meeting, there were approximately [ ] shares of A&P common stock outstanding.
Although A&P declared and paid a special one-time dividend to its stockholders of record on April 17, 2006 equal to $7.25 per share in April 2006, A&P’s policy is to not pay dividends. As such, A&P has not made dividend payments, other than the special one-time dividend just described, in the previous five years and does not intend to pay dividends in the normal course of business in fiscal 2007. A&P is permitted, however, under the terms of its credit agreements, to pay cash dividends on shares of common stock.
Pathmark did not pay any cash dividends to its stockholders during fiscal 2006 and does not currently anticipate paying cash dividends during fiscal 2007. Pathmark is prohibited from paying cash dividends to holders of Pathmark common stock under the terms of its amended and restated $250 million senior secured credit facility dated as of October 1, 2004, as amended, with a group of lenders led by Fleet Retail Group. In addition, Pathmark is restricted from paying cash dividends to holders of Pathmark common stock under the indenture governing its $350 million 8.75% Senior Subordinated Notes, due 2012.
23
| S-4/A | 34th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 34th |
|---|
In addition to general investment risks and the other information included or incorporated by reference into this joint proxy statement/prospectus, you should carefully consider the risk factors described below in evaluating whether to adopt the merger agreement and the transactions contemplated thereby, in the case of Pathmark stockholders, or to approve the A&P share issuance proposal, in the case of A&P stockholders.
Risk Factors Relating to A&P and Pathmark
A&P’s and Pathmark’s businesses are and will be subject to the risks described below relating to the merger. In addition, A&P and Pathmark are, and will continue to be, subject to the risks described in Part I, Item 1A in each of A&P’s Annual Report on Form 10-K for the year ended February 24, 2007 and Quarterly Report on Form 10-Q for the quarter ended June 16, 2007 and Pathmark’s Annual Report on Form 10-K, as amended, for the year ended February 3, 2007 and Quarterly Report on Form 10-Q for the quarter ended May 5, 2007, in each case as filed with the Securities and Exchange Committee (“SEC”) and incorporated by reference into this joint proxy statement/prospectus. See “Where You Can Find More Information” beginning on page 174 for the location of information incorporated by reference into this joint proxy statement/prospectus.
Risk Factors Relating to the Merger
Because the market price of A&P common stock will fluctuate, Pathmark stockholders cannot be sure of the market value of the shares of A&P common stock that they will receive.
The number of shares of A&P common stock to be received by holders of Pathmark common stock in the merger as part of the merger consideration is fixed at 0.12963 of a share of A&P common stock for each share of Pathmark common stock. That number will not be adjusted in the event of any increase or decrease in the price of either A&P common stock or Pathmark common stock. The price of A&P common stock may vary at the effective time of the merger from its price at the date of this joint proxy statement/prospectus and at the date of the special meeting. That variation may be the result of changes in the business, operations or prospects of A&P or Pathmark, market assessments of the likelihood that the merger will be completed and the timing of the merger, regulatory considerations, general market and economic conditions and other factors. In addition to the approval of Pathmark stockholders, completion of the merger is subject to the expiration or termination of the applicable waiting period and any extension of the waiting period under the HSR Act, and the satisfaction of other conditions that may not occur until some time after the special meeting. Therefore, at the time of the Pathmark special meeting, Pathmark stockholders will not know the precise dollar value of the merger consideration they will be entitled to receive upon completion of the merger. Pathmark stockholders are urged to obtain current market quotations for A&P common stock and Pathmark common stock.
Obtaining required approvals and satisfying closing conditions may delay or prevent completion of the merger or reduce the anticipated benefits of the merger.
Completion of the merger is conditioned upon the receipt of certain governmental authorizations, consents, orders and approvals, including the expiration or termination of the applicable waiting period (and any extension of the waiting period) under the HSR Act. These consents, orders and approvals may impose conditions on, or require divestitures relating to, the divisions, operations or assets of A&P or Pathmark. These conditions or divestitures may jeopardize or delay completion of the merger or may reduce the anticipated benefits of the merger. Further, no assurance can be given that the required consents and approvals will be obtained or that the required conditions to closing will be satisfied, and, if all required consents and approvals are obtained and the conditions are satisfied, no assurance can be given as to the terms, conditions and timing of the consents and approvals.
Pursuant to the merger agreement, A&P may be required to dispose of significant assets if required by governmental entities in order to resolve potential antitrust objections to the merger. A&P and Pathmark have agreed to use their respective best efforts to cause the expiration or
24
| S-4/A | 35th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 35th |
|---|
termination of the waiting period under the HSR Act. Subject to A&P’s right to terminate the merger agreement prior to December 5, 2007 in the event that A&P has determined in good faith, subject to certain requirements, that required divestitures would be reasonably likely to exceed $36.0 million of aggregate scheduled store level cashflow, A&P has agreed to use best efforts to take all actions necessary to, among other things, resolve any objections to the merger asserted by governmental authorities under antitrust laws and to prevent or have lifted any court order preventing or delaying the merger. This obligation includes, without limitation, executing settlements, undertakings, consent decrees, stipulations or other agreements and proposing to sell, divest, or otherwise convey any of its assets or the assets to be acquired in the merger, as necessary. Additionally, if the merger agreement is not terminated by December 5, 2007, the limitations on required asset dispositions set forth above will cease to apply, and A&P will remain obligated to use its best efforts to resolve any objections to the merger asserted by governmental authorities under antitrust laws and to prevent or have lifted any court order preventing or delaying the merger. The extent to which asset dispositions will be required and in what amount, and whether A&P will be able to dispose of such assets or, if those assets are sold, at which price they may be sold and the impact that such dispositions may have on A&P’s profitability, is uncertain.
The failure to successfully integrate Pathmark’s business and operations in the expected time frame may adversely affect A&P’s future results.
The success of the merger will depend, in part, on the combined company’s ability to realize the anticipated benefits from combining the businesses of A&P and Pathmark, including, as A&P has announced, anticipated annual integration synergies of approximately $150 million within two years, through cost reductions in overhead, greater efficiencies, increased utilization of support facilities and the adoption of mutual best practices between the two companies. To realize these anticipated benefits, however, the businesses of A&P and Pathmark must be successfully combined. If the combined company is not able to achieve these objectives, the anticipated benefits of the merger may not be realized fully or at all or may take longer to realize than expected.
A&P and Pathmark have operated and, until the completion of the merger, will continue to operate independently. It is possible that the integration process could result in the loss of key employees, as well as the disruption of each company’s ongoing businesses or inconsistencies in standards, controls, procedures and policies, any or all of which could adversely affect A&P’s ability to maintain relationships with customers and employees after the merger or to achieve the anticipated benefits of the merger. Integration efforts between the two companies will also divert management attention and resources. These integration matters could have an adverse effect on each of A&P and Pathmark.
The market price for A&P common stock may be affected by factors different from those affecting the shares of Pathmark.
Upon completion of the merger, holders of Pathmark common stock will become holders of A&P common stock. A&P’s businesses differ from those of Pathmark, and accordingly the results of operations of the combined company will be affected by factors different from those currently affecting the results of operations of Pathmark. For a discussion of the businesses of A&P and Pathmark and of certain factors to consider in connection with those businesses, see the documents incorporated by reference into this joint proxy statement/prospectus and referred to under “Where You Can Find More Information.”
Some directors, executive officers and significant stockholders of A&P and Pathmark have interests in the merger that may differ from the interests of the A&P and Pathmark stockholders.
When considering the Pathmark board of directors’ unanimous recommendation that the Pathmark stockholders vote “FOR” the proposal to approve and adopt the merger agreement and the transactions contemplated thereby, including the merger, and the A&P board of directors’ unanimous recommendation that A&P stockholders vote “FOR” the proposal to approve the issuance of shares of A&P common stock pursuant to the merger agreement, you should be aware that certain directors and executive officers of Pathmark and A&P, the Yucaipa Investors, Pathmark’s largest stockholder, and Tengelmann, A&P’s largest stockholder, each have interests in the merger agreement and the merger that are different from, and may conflict with, your interests.
25
| S-4/A | 36th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 36th |
|---|
In addition, subject to certain conditions, in connection with the merger, Gregory Mays, a director of Pathmark, will be elected by the existing A&P directors to fill the existing vacant position on the A&P board of directors without stockholder action, as provided for under the bylaws of A&P and in accordance with Maryland law. The directors and executive officers of Pathmark will receive certain benefits in connection with the merger, including accelerated vesting of stock options and restricted stock. Additionally, certain executive officers may be entitled to receive severance payments in connection with the merger. A&P has agreed to continue certain indemnification arrangements for directors and executive officers of Pathmark. Affiliates of the Yucaipa Investors will receive certain fees in connection with the merger. Additionally, warrants to purchase Pathmark common stock owned by the Yucaipa Investors will be converted into warrants to acquire A&P common stock and the Yucaipa Investors will receive certain registration rights for shares of A&P common stock acquired by the Yucaipa Investors in connection with the merger and those issuable upon conversion of the Yucaipa Investors’ warrants. Tengelmann has entered into a stockholder agreement with A&P whereby Tengelmann will have certain approval, registration, preemptive and other rights after the merger. The A&P and Pathmark boards of directors were aware of these interests and considered them, among other matters, in authorizing and advising stockholder approval of the merger agreement and the A&P share issuance. See “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Interests of Certain Persons in the Merger.”
The shares of A&P common stock to be received by Pathmark stockholders as a result of the merger will have different rights than shares of Pathmark common stock.
Following completion of the merger, Pathmark stockholders will no longer be stockholders of Pathmark, a Delaware corporation, but will instead be stockholders of A&P, a Maryland corporation. There will be important differences between Pathmark stockholders’ current rights and the rights to which they will be entitled as stockholders of A&P as a result of differences between Delaware law and Maryland law and the governing documents of Pathmark and A&P. See “Adoption of the Merger Agreement (Pathmark Proposal 1)—Comparison of Stockholders’ Rights” for a discussion of the different rights associated with A&P and Pathmark common stock.
Two putative class action complaints were filed and subsequently consolidated and amended in connection with the transactions and, if decided adversely to the defendants, could result in the entry of an injunction against the completion of the merger and an order for other relief.
Two putative class action complaints were filed in New Jersey State court, on March 6 and March 12, 2007, and were subsequently consolidated on June 15, 2007 and amended on July 16, 2007 (Superior Court of the State of New Jersey, Middlesex County, Civil Action No. C-111-07), alleging breach of fiduciary duty of the directors of Pathmark, as well as aiding and abetting the breach of that duty by Pathmark and A&P. The consolidated amended complaint seeks to enjoin the merger. While this case is now in the early stages, A&P and Pathmark believe that the case is without merit. Any judgments, however, in respect of this lawsuit adverse to A&P and Pathmark may adversely affect A&P and Pathmark’s ability to consummate the merger.
Risks Relating to A&P’s Operations (Including Pathmark) After Completion of the Merger
General economic conditions affecting the food industry may affect A&P’s business and may adversely affect A&P’s operating results.
The retail food and food distribution industries are sensitive to a number of economic conditions such as (i) food price deflation or inflation, (ii) softness in local and national economies, (iii) increases in commodity prices, (iv) the availability of favorable credit and trade terms, and (v) other economic conditions that may affect consumer buying habits. Any one or more of these economic conditions can affect A&P’s retail sales, the demand for products A&P distributes to its retailer customers, its operating costs and other aspects of its business.
Threats or potential threats to food safety may adversely affect A&P’s business.
Acts of war, threats of terror, acts of terror or other criminal activity directed at the grocery or drug store industry, the transportation industry, or computer or communications systems, could increase security costs, adversely affect A&P’s operations, or impact consumer behavior and
26
| S-4/A | 37th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 37th |
|---|
spending as well as customer orders. Other events that give rise to actual or potential food contamination, drug contamination, or food-borne illness could have an adverse effect on A&P’s operating results.
A&P faces a high level of competition in the retail food and food distribution businesses from several retail formats, which may adversely affect A&P’s profitability.
The industries in which A&P competes are extremely competitive. Both the retail food and food distribution businesses are subject to competitive practices that may affect (i) the prices at which A&P is able to sell products at its retail locations; (ii) sales volume; (iii) the ability of A&P’s distribution customers to sell products it supplies, which may affect future orders; and (iv) A&P’s ability to attract and retain customers. In addition, the nature and extent of consolidation in the retail food and food distribution industries could affect A&P’s competitive position or that of its distribution customers in the markets it serves.
A&P’s retail food business faces competition from other retail chains, supercenters, nontraditional competitors and emerging alternative formats in the markets where it has retail operations. In the food distribution business, A&P’s success depends in part on the ability of its independent retailer customers to compete effectively, its ability to attract new customers, and its ability to supply products in a cost-effective manner. Declines in the level of retail sales activity of distribution customers due to competition, consolidations of retailers or competitors, increased self-distribution by A&P’s customers, or the entry of new or nontraditional distribution systems into the industry may adversely affect A&P’s revenues.
Risks Relating to Financing
A&P will take on substantial additional indebtedness to finance the merger, which will decrease A&P’s business flexibility and increase its borrowing costs.
Upon completion of the merger, A&P will have consolidated indebtedness that will be substantially greater than its indebtedness prior to the merger. The increased indebtedness and higher debt- to-equity ratio of A&P in comparison to that of A&P on a historical basis will have the effect, among other things, of reducing the flexibility of A&P to respond to changing business and economic conditions and increasing borrowing costs. See “Unaudited Pro Forma Condensed Combined Financial Information.”
The financing arrangements that A&P expects to enter into in connection with the merger will contain restrictions and limitations that could significantly impact A&P’s ability to operate its business.
A&P is incurring significant debt in connection with the merger. It is expected that A&P will utilize much of the financing to be made available pursuant to the financing commitments discussed in “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Financing” to fund a portion of the cash consideration payable to the Pathmark stockholders in the merger. A&P, on a pro forma basis, will have approximately $615 million of debt under its new senior secured revolving credit facility, and either $780 million in aggregate principal amount of new senior secured notes or a $780 million bridge facility. In addition, approximately $[ ] billion of existing debt of A&P and Pathmark will remain outstanding following the merger.
This debt could limit A&P’s financial and operating flexibility, including by requiring A&P to dedicate a substantial portion of its cash flow from operations and the proceeds of equity issuances to the repayment of its debt and the interest on its debt, making it more difficult for the combined company to obtain additional financing on favorable terms, limiting the combined company’s ability to capitalize on significant business opportunities and making the combined company more vulnerable to economic downturns.
A&P expects that the agreements governing the indebtedness that it will incur in connection with the merger will contain covenants that, among other things, will limit the ability of A&P and certain of its subsidiaries to:
27
| S-4/A | 38th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 38th |
|---|
|
||||||||||||||||||||
• |
|
make payments in respect of, or redeem or acquire, debt or equity issued by A&P or its subsidiaries, including the payment of dividends on A&P common stock; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
incur additional indebtedness; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
incur guarantee obligations; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
pay dividends; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
create liens on assets; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
enter into sale and leaseback transactions; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
make investments, loans or advances; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
enter into hedging transactions; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
engage in mergers, consolidations or sales of all or substantially all of their respective assets; and |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
engage in certain transactions with affiliates. |
||||||||||||||||||
In addition, A&P will be required to comply with certain financial covenants set forth in these agreements. Certain of these agreements will require A&P to make an offer to purchase the related debt if A&P experiences specified changes of control or sells certain assets, and A&P’s failure to purchase such debt agreements in accordance with the terms would result in a default under such agreements.
In addition, if A&P fails to maintain a specified minimum level of borrowing capacity under the senior secured revolving credit facility, which we refer to as the “ABL Facility,” which is more fully described in “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Financing,” A&P will then be subject to a financial covenant under the ABL Facility that will obligate A&P to make mandatory prepayments under the ABL Facility to the extent the minimum level of borrowing capacity is exceeded.
A&P’s ability to comply with this covenant in future periods will depend on its ongoing financial and operating performance, which in turn will be subject to economic conditions and to financial, market and competitive factors, many of which are beyond A&P’s control. The ability to comply with this covenant in future periods will also depend on A&P’s ability to successfully implement A&P’s overall business strategy and realize contemplated merger synergies.
Various risks, uncertainties and events beyond A&P’s control could affect its ability to comply with the covenants contained in its debt agreements. Failure to comply with any of the covenants in its existing or future financing agreements could result in a default under those agreements and under other agreements containing cross-default provisions. A default would permit lenders to accelerate the maturity of the debt under these agreements and to foreclose upon any collateral securing the debt. Under these circumstances, A&P might not have sufficient funds or other resources to satisfy all of its obligations. In addition, the limitations imposed by financing agreements on A&P’s ability to incur additional debt and to take other actions might significantly impair its ability to obtain other financing. A&P cannot assure you that it will be granted waivers or amendments to these agreements if for any reason it is unable to comply with these agreements, or that it will be able to refinance its debt on terms acceptable to it, or at all.
The terms of A&P’s debt financing arrangements have not been finalized and are subject to market risk, which could result in less favorable borrowing costs and financial conditions than anticipated.
The terms of the various credit facilities and debt financing arrangements described under “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Financing” reflect the current state of discussions with respect to financing and have not yet been finalized. As such, those terms may materially change depending on market conditions at the time of the incurrence or offering of such indebtedness. The economic terms of the indebtedness, including interest rates and redemption prices, will be determined as part of the offering process and will vary depending on market conditions. Adverse market conditions could result in higher than expected redemption prices or subject A&P to restrictive covenants that impose restrictions and limitations that are in
28
| S-4/A | 39th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 39th |
|---|
addition to, or more restrictive than, those currently expected. The funding of the bridge facility, if it occurs, would exacerbate these risks and could adversely affect the ability of A&P and/or its subsidiaries to obtain other debt financing on favorable terms. In addition, if the bridge facility is funded in lieu of issuing the notes, the interest expense payable by the borrower could increase. See “Unaudited Pro Forma Condensed Combined Financial Information.”
A&P cannot assure you that it will be able to generate sufficient cash flow needed to service its indebtedness, and its inability to do so would adversely affect A&P’s financial condition.
A&P’s ability to make scheduled payments on its indebtedness and to fund planned capital expenditures will depend on the ability of A&P and its subsidiaries to generate cash flow in the future. A&P’s future performance is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond its control. In addition, A&P’s ability to borrow funds in the future will depend on the satisfaction of the covenants in A&P’s credit facilities and its other debt agreements and other financing arrangements it may enter into in the future. In the event that the credit facilities need to be refinanced, A&P cannot assure you that it will be able to do so or obtain additional financing, particularly because of its anticipated high levels of debt and the debt incurrence restrictions imposed by its debt agreements, as well as prevailing market conditions. A&P cannot assure you that its business will generate sufficient cash flow from operations or that future borrowings will be available in an amount sufficient to enable A&P to service its debt and fund its other liquidity needs.
If A&P’s cash flow and capital resources are insufficient to fund its debt service obligations, A&P may be forced to reduce or delay capital expenditures, sell assets or seek to obtain additional equity capital, or refinance its indebtedness or obtain additional financing. In the future, A&P’s cash flow and capital resources may not be sufficient for payments of interest on and principal of its debt and there can be no assurance that any of, or a combination of, such alternative measures would provide A&P with sufficient cash flows. In addition, such alternative measures could have an adverse effect on A&P’s business, financial condition and results of operations.
In the absence of sufficient operating results and resources, A&P could face substantial liquidity problems and might be required to dispose of material assets or operations to meet its debt service and other obligations or otherwise risk default under the agreements governing its indebtedness. These agreements are expected to restrict A&P’s ability to dispose of assets and restrict the use of proceeds from any such dispositions. If required, A&P cannot be sure as to the timing of such sales or adequacy of the proceeds that it could realize therefrom.
An increase in interest rates would increase the cost of servicing A&P’s debt and could reduce A&P’s profitability.
A significant portion of the debt that A&P will incur in connection with the merger will bear interest at variable rates. As a result, an increase in interest rates, whether because of an increase in market interest rates or a decrease in A&P’s credit worthiness, would increase the cost of servicing A&P’s debt and could materially reduce A&P’s profitability and cash flows. The impact of such an increase would be more significant for A&P than it would be for less leveraged companies because of A&P’s substantial debt.
A&P’s bridge facility and ABL Facility agreement may contain conditions that may not be satisfied, in which case A&P would need to arrange for alternative sources of financing, which could result in a less favorable financial condition than anticipated.
A&P has entered into a debt financing commitment letter with respect to a bridge facility and the ABL Facility under which it may borrow up to $1.395 billion. The commitment letter contemplates credit facilities containing various conditions to A&P’s ability to borrow loans thereunder, including conditions that:
|
||||||||||||||||||||
• |
|
there has been no change, event or circumstance that has occurred that has had a material adverse effect on Pathmark that is continuing, or would reasonably be expected to have a material adverse effect on Pathmark since the date of the merger agreement; and | ||||||||||||||||||
29
| S-4/A | 40th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 40th |
|---|
|
||||||||||||||||||||
|
• |
|
no agreement, order or decree has been entered into, or issued, requiring A&P, Pathmark or their respective subsidiaries to divest, dispose of or sell off any businesses or assets representing more than $36.0 million of aggregate scheduled store level cashflow. |
||||||||||||||||||
If these conditions are not satisfied, or any of the other conditions contained in the commitment letter are not satisfied or the proceeds of the financing are unavailable for any reason, A&P may have to arrange for alternative sources of financing, which may be more expensive for A&P, may have an adverse impact on A&P’s post-merger capital structure, or may be unavailable.
Despite current indebtedness levels, A&P and its subsidiaries may still be able to incur substantially more debt. This could further exacerbate the risks associated with A&P’s substantial leverage.
A&P and its subsidiaries may be able to incur substantial additional indebtedness in the future. Although the contemplated facilities contain restrictions on the incurrence of additional indebtedness, these restrictions are subject to a number of significant qualifications and exceptions, and any indebtedness incurred in compliance with these restrictions could be substantial. For example, A&P will have the right under the ABL Facility to request up to $100 million of additional commitments under this facility, although the lenders under this facility will not be under any obligation to provide any such additional commitments. Any increase in commitments under this facility will be subject to customary conditions precedent, and A&P’s ability to borrow under this facility as so increased would remain limited by the amount of the borrowing base. The bridge facilities would allow A&P to incur this additional indebtedness under the ABL Facility without any restriction.
A&P’s ability to borrow under its revolving credit facility will be limited based on the value of a borrowing base that may fluctuate, which may diminish A&P’s ability to use the revolving credit facility to meet its financing needs as anticipated.
The contemplated ABL Facility will provide A&P with revolving loans, the amounts of which are based upon the estimated value of the borrowing base. The borrowing base will be comprised of A&P assets such as inventory, credit card receivables, prescription lists, prescription receivables, Coinstar receivables, real estate and leaseholds. If any estimates of the value of these assets are diminished, the borrowing base may be reduced, which may affect the amounts available under the ABL Facility. Furthermore, A&P’s ability to borrow under the ABL Facility is subject to borrowing base limitations, including an excess availability reserve.
30
| S-4/A | 41st "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 41st |
|---|
SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS
Some of the statements contained or incorporated by reference into this joint proxy statement/prospectus, including those relating to A&P’s and Pathmark’s strategies and other statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “will,” “should,” “may,” expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates” and similar expressions, are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements include the information concerning possible or assumed future results of operations of A&P and Pathmark as set forth under “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—A&P’s Reasons for the Merger; Recommendation of the A&P Board of Directors,” “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Pathmark’s Reasons for the Merger; Recommendation of the Pathmark Board of Directors,” “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Opinion of A&P’s Financial Advisor” and “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Opinion of Pathmark’s Financial Advisor.” These statements are not historical facts but instead represent only A&P’s and Pathmark’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict, which may include the risk factors set forth above and other market, business, legal and operational uncertainties discussed elsewhere in this document and the documents that are incorporated herein by reference. Those uncertainties include, but are not limited to:
|
||||||||||||||||||||
| ||||||||||||||||||||
• |
|
the ability to obtain requisite governmental approvals for the merger on the proposed terms and schedule, including the expiration or termination of the waiting period under the HSR Act, including any extension of the waiting period; |
||||||||||||||||||
| ||||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
the failure of the Pathmark stockholders to adopt the merger agreement and the transactions contemplated thereby, including the merger; |
||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
|
• |
|
the failure of the A&P stockholders to approve the issuance of A&P’s common stock pursuant to the merger agreement; |
||||||||||||||||||
| ||||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
the risk that the businesses of A&P and Pathmark will not be successfully integrated following the consummation of the merger; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
disruption from the merger, including lost business opportunities and difficulty maintaining relationships with employees, customers and suppliers; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
legal risks, including litigation, whether or not related to the merger, and legislative and regulatory developments; and |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
changes in general economic and market conditions. |
||||||||||||||||||
A&P’s and Pathmark’s actual results and financial conditions may differ, perhaps materially, from the anticipated results and financial conditions in any forward-looking statements, and, accordingly, readers are cautioned not to place undue reliance on such statements.
For more information concerning factors that could affect A&P’s and Pathmark’s future results and financial conditions, see, in addition to the factors discussed under “Risk Factors,” of this joint proxy statement/prospectus, “Management’s Discussion and Analysis” and “Risk Factors” in each of A&P’s annual report on Form 10-K for the year ended February 24, 2007 and Pathmark’s annual report on Form 10-K, as amended, for the year ended February 3, 2007, which are incorporated by reference into this joint proxy statement/prospectus. A&P and Pathmark undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
31
| S-4/A | 42nd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 42nd |
|---|
Date, Time and Place
The A&P special meeting will be held at The Woodcliff Lake Hilton, 200 Tice Boulevard, Woodcliff Lake, New Jersey, on [ ], [ ], 2007, at 9:00 a.m., Eastern Daylight Time.
Purpose of the Special Meeting
At the special meeting, A&P stockholders will be asked:
|
||||||||||||||||||||
1. |
|
to consider and vote upon a proposal to approve the issuance of shares of A&P common stock pursuant to the merger agreement, |
||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
|
2. |
|
to consider and vote upon a proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies, and |
||||||||||||||||||
|
||||||||||||||||||||
|
3. |
|
to transact any other business that may properly be brought before the special meeting and any adjournments or postponements thereof. |
||||||||||||||||||
| ||||||||||||||||||||
The A&P Board’s Recommendation
The A&P board of directors has unanimously determined that the merger agreement and the A&P proposals are advisable and in the best interests of A&P and its stockholders and unanimously recommends that A&P stockholders vote “FOR” the proposal to approve the issuance of shares of A&P common stock pursuant to the merger agreement and “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies.
Record Date; Required Vote; How to Vote; Quorum
The A&P board of directors has fixed the close of business on [ ], 2007 as the record date for determining the holders of A&P common stock entitled to notice of, and to vote at, the special meeting. Only holders of record of A&P common stock at the close of business on the record date will be entitled to notice of, and to vote at, the special meeting or any adjournment or postponement of the special meeting.
As of the record date, [ ] shares of A&P common stock were issued and outstanding and entitled to vote at the special meeting and there were approximately [ ] holders of record of A&P common stock. Each share of A&P common stock entitles the holder to one vote on each matter to be considered at the special meeting. If you are a record holder of A&P common stock, you may vote your shares of A&P common stock in person at the special meeting or by proxy as described below under “—Voting by Proxy; Revocation of Proxies.”
The presence in person or by proxy at the special meeting of the holders of at least a majority of the outstanding shares of A&P common stock entitled to vote at the meeting will constitute a quorum for the special meeting. Properly signed proxies that are marked “abstain” are known as abstentions. Abstentions will be counted for the purposes of determining whether a quorum exists at the special meeting.
The stock issuance proposal requires the affirmative vote of a majority of all votes cast by the holders of common stock at a meeting at which a quorum is present, provided that the total votes cast on the proposal represent at least a majority of the outstanding shares of A&P common stock entitled to vote on the proposal. Because approval is based on the affirmative vote of a majority of votes cast, an A&P stockholder’s failure to vote will not affect the outcome of the vote on the proposal, assuming more than a majority of the outstanding shares are voted on the proposal. Because the NYSE treats abstentions as votes cast with respect to the stock issuance proposal, an abstention will have the same effect as a vote “AGAINST” this proposal.
Tengelmann has agreed to vote all of its shares of A&P common stock, approximately 53% of the outstanding A&P common stock as of the A&P record date, in favor of the issuance of A&P
32
| S-4/A | 43rd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 43rd |
|---|
common stock in the merger and the amendment to the A&P charter. This means that the approval of the issuance of the A&P common stock pursuant to the merger agreement is assured.
The adoption of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote of a majority of the votes cast by the holders of A&P common stock at the special meeting.
Acting upon any procedural matters incident to the conduct of the special meeting will require the affirmative vote of a majority of the votes cast by the holders of A&P common stock with respect to such proposal.
A&P does not expect that any matter other than the proposals listed above will be brought before the special meeting. If, however, other matters are properly brought before the special meeting, or any adjournment of the special meeting, the persons named as proxies will vote in accordance with their discretion.
Voting by Proxy; Revocation of Proxies
Each copy of this joint proxy statement/prospectus mailed to A&P stockholders is accompanied by a form of proxy and a self-addressed postage pre-paid envelope.
If you are a registered stockholder (that is, if you hold your A&P common stock in certificate form), you should either complete and return the proxy card accompanying this joint proxy statement/prospectus, or authorize a proxy by telephone, through the Internet or by any other electronic means by following the instructions included with your proxy card, in each case, to ensure that your vote is counted at the special meeting, or at any adjournment or postponement thereof, regardless of whether you plan to attend the special meeting.
If you hold your shares through a bank, brokerage firm or nominee, you should follow the separate voting instructions, if any, provided by the bank, brokerage or nominee with this joint proxy statement/prospectus. Your bank, brokerage firm or nominee may permit proxy authorization through the Internet or by telephone. Please contact your bank, brokerage firm or nominee to determine how to vote your proxy.
You can revoke your proxy at any time before the vote is taken at the special meeting. If you have not voted through your bank, brokerage firm or nominee, you may revoke your proxy before the proxy is voted by:
|
||||||||||||||||||||
• |
|
delivering a written notice of revocation of proxy, which is dated a later date than the initial proxy, to A&P’s Secretary; |
||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
delivering a duly executed proxy bearing a later date than the initial proxy; |
||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
|
• |
|
authorizing a new proxy by telephone or through the Internet at a later time, but not later than 11:59 p.m. (Eastern Daylight Time) on [ ], 2007 or the day before the meeting date if the special meeting is adjourned or postponed; or |
||||||||||||||||||
| ||||||||||||||||||||
|
||||||||||||||||||||
|
• |
|
voting in person at the special meeting; however, simply attending the special meeting without voting will not revoke an earlier proxy. |
||||||||||||||||||
To submit a written notice of revocation or other communications about revoking your proxy with respect to your shares of A&P common stock, or to request a new proxy card, you should contact:
The Great Atlantic & Pacific Tea Company, Inc.
Two Paragon Drive
Montvale, New Jersey 07645
Telephone: (201) 573-9700
Attention: Secretary
If your shares of A&P common stock are held in street name, you should follow the instructions of your bank, brokerage firm or nominee regarding the revocation of proxies. If your bank, brokerage firm or nominee allows you to authorize a proxy by telephone or through the
33
| S-4/A | 44th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 44th |
|---|
Internet, you may be able to change your vote by submitting a proxy again by telephone or through the Internet.
All shares represented by valid proxies received through this solicitation, and not revoked, will be voted in accordance with your instructions on the proxy card. If you authorize a proxy by telephone or through the Internet, your shares will be voted at the special meeting as instructed.
If you sign and return your proxy card for your shares of A&P common stock without specifying on the proxy card, as to one or both proposals, how you want your shares of A&P common stock voted, your proxy will be voted (1) “FOR” the proposal to approve the issuance of A&P common stock in connection with the merger, if you do not specify a vote “FOR” or “AGAINST” that proposal; and (2) “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies, if you do not specify a vote “FOR” or “AGAINST” that proposal. We intend, with respect to any procedural matters incident to the conduct of the special meeting, that the shares represented by properly submitted proxies will be voted, or not voted, by and at the discretion of the persons named as proxies on the proxy card.
A&P stockholders should NOT send stock certificates with their proxy cards. A&P stockholders will continue to hold their A&P stock certificates following the merger and are not required to take any action with respect to their A&P stock certificates.
Effects of Abstentions
Absent specific instructions from the beneficial owner of shares, brokers may not vote shares of A&P common stock with respect to the share issuance or the adjournment or postponement of the special meeting, any other matters that may properly come before the special meeting, or any adjournment of the special meeting. Because the NYSE treats abstentions as votes cast with respect to the stock issuance proposal, an abstention will have the same effect as a vote “AGAINST” this proposal. Because Maryland law does not treat abstentions as votes cast with respect to the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies, an abstention will have no effect on the outcome of the vote on such proposal.
Share Ownership of Management and Certain Stockholders
At the close of business on the A&P record date, A&P’s directors and executive officers as a group owned and were entitled to vote [ ] shares of A&P common stock, representing approximately [ ]% of the outstanding shares of A&P common stock entitled to vote (approximately [ ]% if the shares held by Tengelmann are excluded). [All of the directors and executive officers of A&P that are entitled to vote at the A&P special meeting have indicated that they currently intend to vote their shares of A&P common stock in favor of the proposal to approve the issuance of A&P common stock in connection with the merger.]
Tengelmann has entered into a voting agreement with Pathmark pursuant to which Tengelmann has agreed to vote its shares of A&P common stock, approximately 53% of the shares of A&P common stock outstanding as of the A&P record date, in favor of the proposal to approve the issuance of A&P common stock in connection with the merger and against any proposal that would compete with or delay the merger, subject to specified exceptions. See “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Interests of Certain Persons in the Merger.”
Solicitation of Proxies
A&P will bear the costs of soliciting proxies from its stockholders. Other than as described in more detail under “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger Agreement—Termination Fees and Expenses,” each of A&P and Pathmark will generally bear its own costs and expenses in connection with the merger. In addition to soliciting proxies by mail, directors, officers and employees of A&P, without receiving additional compensation therefor, may solicit proxies by telephone, by facsimile or in person. Arrangements may also be made with brokerage firms and other custodians, nominees and fiduciaries to forward solicitation materials to the beneficial owners of shares held of record by those persons, and A&P will reimburse those
34
| S-4/A | 45th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 45th |
|---|
brokerage firms, custodians, nominees and fiduciaries for reasonable out-of-pocket expenses incurred by them in connection with those actions. In addition, MacKenzie Partners, Inc. (“Mackenzie Partners”) has been retained by A&P to assist in the solicitation of proxies. MacKenzie Partners may contact holders of shares of A&P common stock by mail, telephone, facsimile, telegraph or personal interviews and may request brokers, dealers and other nominee stockholders to forward materials to beneficial owners of shares of A&P common stock. MacKenzie Partners will receive reasonable and customary compensation for its services (estimated at $[ ]) and will be reimbursed for certain reasonable out-of-pocket expenses and other customary costs.
Adjournments
Although it is not expected, the A&P special meeting may be adjourned or postponed for the purpose of soliciting additional proxies or for any other reason. The Maryland General Corporation Law provides that if the special meeting is convened on the date for which it was called, any adjournment may be made from time to time to a date not more than 120 days after the original record date without further notice. The bylaws of A&P further state that if there is no quorum present at the A&P special meeting, the holders of a majority of the outstanding shares of voting stock present in person or represented by proxy at the A&P special meeting may adjourn the meeting from time to time, without notice other than an announcement made at the special meeting, until the requisite amount of voting stock shall be present. Any signed proxies received by A&P which are otherwise silent on the matter will be voted in favor of an adjournment in these circumstances. Any adjournment of the special meeting will allow A&P stockholders who have already sent in their revocable proxies to revoke them at any time prior to their use.
Date, Time and Place
This joint proxy statement/prospectus is being furnished to Pathmark stockholders as part of the solicitation of proxies by the Pathmark board of directors for use at the special meeting to be held on [ ], 2007, at [ ] a.m., Eastern Daylight Time, at Pathmark’s corporate headquarters, 200 Milik Street, Carteret, New Jersey 07008.
Purpose of the Special Meeting
At the special meeting, Pathmark stockholders will be asked:
|
||||||||||||||||||||
1. |
|
to consider and vote upon a proposal to approve and adopt the Agreement and Plan of Merger, dated March 4, 2007, by and among Pathmark, A&P and Merger Sub, and the transactions contemplated by the merger agreement, as amended from time to time, including the merger, pursuant to which Merger Sub would merge with and into Pathmark and each outstanding share of Pathmark common stock would be converted into the right to receive $9.00 in cash and 0.12963 shares of A&P common stock; |
||||||||||||||||||
|
||||||||||||||||||||
|
2. |
|
to consider and vote upon a proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies; and |
||||||||||||||||||
|
||||||||||||||||||||
|
3. |
|
to consider and vote on such other matters as may properly come before the special meeting or any adjournment or postponement thereof. |
||||||||||||||||||
The Pathmark Board’s Recommendation
The Pathmark board of directors has unanimously determined that that the merger is advisable, fair to and in the best interests of Pathmark and the Pathmark stockholders and has approved the merger agreement and the merger. Accordingly, the Pathmark board of directors unanimously recommends that Pathmark stockholders vote “FOR” the proposal to approve and adopt the merger agreement and the transactions contemplated thereby, including the merger. See “Adoption of the
35
| S-4/A | 46th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 46th |
|---|
Merger Agreement (Pathmark Proposal 1)—The Merger—Pathmark’s Reasons for the Merger; Recommendation of the Pathmark Board of Directors.”
Additionally, the Pathmark board of directors unanimously recommends that the Pathmark stockholders vote “FOR” the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies.
Record Date
The record holders of shares of Pathmark common stock as of the close of business on [ ], 2007, the record date for the Pathmark special meeting, are entitled to receive notice of, and to vote at, the special meeting. On the record date, there were [ ] outstanding shares of Pathmark common stock.
Required Vote; How to Vote
Each outstanding share of Pathmark common stock on [ ], 2007 entitles the holder to one vote at the special meeting. Adoption of the merger agreement and the transactions contemplated thereby, including the merger, requires the affirmative vote “FOR” the proposal to adopt the merger agreement by a majority of the shares of Pathmark common stock outstanding on the record date and entitled to vote on the matter. The adoption of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies requires the affirmative vote “FOR” the proposal by a majority of shares of Pathmark common stock represented in person or by proxy at the special meeting and entitled to vote thereon. In the absence of a quorum, holders of a majority of the shares present in person or represented by proxy may adjourn the meeting until a quorum shall be attained. The approval of any other such other matters as may be properly presented incident to the conduct of the special meeting requires the affirmative vote “FOR” the approval of any such proposed transaction by a majority of the shares present in person or by proxy at the meeting and entitled to vote on the matter. In order for your shares of Pathmark common stock to be included in the vote, you must submit a proxy to have your shares voted by completing, signing, dating and returning the enclosed proxy or by voting in person at the special meeting.
If your shares of Pathmark common stock are held in street name by your bank, brokerage firm or nominee, you should instruct them how to vote your shares of Pathmark common stock using the instructions provided by them. If you have not received such voting instructions or require further information regarding such voting instructions, contact your bank, brokerage firm or nominee and they can give you directions on how to vote your shares. Under NASDAQ rules, banks, brokerage firms or nominees who hold shares of common stock in street name for customers without investment discretion over a customer’s account pursuant to an advisory contract and who have not been designated in writing by the customer to vote proxies may not exercise their voting discretion in respect of the proposal to adopt the merger agreement or the proposal to adjourn or postpone the meeting, if necessary, to solicit additional proxies. Accordingly, absent specific instructions from the beneficial owner of such shares, banks, brokerage firms or nominees are not empowered to vote such shares at the special meeting on the proposal to adopt the merger agreement or the proposal to adjourn or postpone the meeting, if necessary, to solicit additional proxies. If your shares are held in street name and you do not provide your bank, brokerage firm or nominee with instructions as to how such shares are to be voted, your shares will not be submitted in connection with the special meeting. Because adoption of the merger agreement and the transactions contemplated thereby, including the merger, requires the affirmative vote “FOR” the approval of the proposal to adopt the merger agreement by a majority of shares of Pathmark common stock outstanding on the record date and entitled to vote on the matter, abstentions and failures to vote by you will have the same effect as a vote “AGAINST” the proposal. Because approval of the proposal to adjourn or postpone the meeting, if necessary, to solicit additional proxies, and approval of any other such matters as may be properly presented incident to the conduct of the special meeting requires the affirmative vote “FOR” the approval of any such matters by a majority of the shares present in person or by proxy at the meeting and entitled to vote on the matter, abstentions will count as a vote “AGAINST” the proposed matters, and the failure to attend the meeting and vote in person, to
36
| S-4/A | 47th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 47th |
|---|
submit a proxy, or to instruct your bank, brokerage firm or nominee on how to vote your shares will not affect the outcome of the proposal.
Quorum
A quorum is necessary to hold the Pathmark special meeting. The holders of a majority of the outstanding shares of Pathmark common stock on [ ], 2007, represented in person or by proxy and entitled to vote at the Pathmark special meeting, will constitute a quorum for purposes of the Pathmark special meeting. For purposes of determining the presence of a quorum, abstentions will be included in determining the number of shares present and entitled to vote at the meeting; however, because brokers are not entitled to vote on the proposal to adopt the merger agreement absent specific instructions from the beneficial owner, shares held by brokers with respect to which instructions have not been provided will not be included in the number of shares present and entitled to vote at the meeting for purposes of establishing a quorum. Any shares of Pathmark common stock held in treasury by Pathmark or by any of its subsidiaries are not considered to be outstanding for purposes of determining a quorum. In the absence of a quorum, holders of a majority of the shares present or represented by proxy at the special meeting may adjourn the meeting until a quorum is present. Once a share is represented at the special meeting, it will be counted for the purpose of determining a quorum at the special meeting and any adjournment or postponement of the special meeting. If a new record date is set for the adjourned special meeting, however, then a new quorum will have to be established.
Proxies; Revocation
Each copy of this joint proxy statement/prospectus mailed to Pathmark stockholders is accompanied by a form of proxy and a self-addressed postage pre-paid envelope. If you are a registered stockholder (that is, if you hold your Pathmark common stock in certificate form), you should either complete and return the proxy card accompanying this joint proxy statement/prospectus to ensure that your vote is counted at the special meeting, or at any adjournment or postponement thereof, regardless of whether you plan to attend the special meeting.
If you vote your shares of Pathmark common stock by properly completing, signing and dating the enclosed proxy card, your shares will be voted at the Pathmark special meeting as you indicate on your proxy card. If no instructions are indicated on your signed and dated proxy card, your shares of common stock will be voted “FOR” the approval and adoption of the merger agreement and transactions contemplated thereby, including the merger, will be voted “FOR” the adoption of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies and will be counted in accordance with the recommendations of Pathmark’s board of directors on any other matters properly brought before the Pathmark special meeting for a vote.
You may revoke your proxy at any time before the vote is taken at the Pathmark special meeting. To revoke your proxy, you must either properly advise Pathmark’s Secretary in writing, deliver a proxy dated after the date of the proxy you wish to revoke or attend the Pathmark special meeting and vote your shares in person. Attendance at the Pathmark special meeting will not by itself constitute revocation of a proxy. If you have instructed your bank, brokerage firm or nominee to vote your Pathmark shares, the above-described options for revoking your proxy do not apply and instead you must follow the directions provided by them to revoke your proxy.
To submit a written notice of revocation or other communications about revoking your proxy with respect to your shares of Pathmark common stock, or to request a new proxy card, you should contact:
Pathmark Stores, Inc.
200 Milik Street
Carteret, New Jersey 07008
Telephone: (732) 499-3000
Attention: Secretary
37
| S-4/A | 48th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 48th |
|---|
Pathmark does not expect that any matter other than the proposal to adopt and approve the merger agreement and the transactions contemplated thereby, including the merger, will be brought before the Pathmark special meeting. If, however, such a matter is properly presented at the special meeting or any adjournment or postponement thereof, the persons appointed as proxies will have discretionary authority to vote the shares represented by duly executed proxies in accordance with their discretion and judgment.
Solicitation of Proxies
Pathmark will pay the cost of this proxy solicitation. In addition to soliciting proxies by mail, directors, officers and employees of Pathmark may solicit proxies personally and by telephone, facsimile or other electronic means of communication. These persons will not receive additional or special compensation for such solicitation services. Arrangements may also be made with brokerage firms and other custodians, nominees and fiduciaries to forward solicitation materials to the beneficial owners of shares held of record by those persons, and Pathmark will reimburse those brokerage firms, custodians, nominees and fiduciaries for reasonable out-of-pocket expenses incurred by them in connection with those actions. In addition, Mellon Investor Services LLC has been retained by Pathmark to assist in the solicitation of proxies. Mellon Investor Services LLC may contact holders of shares of Pathmark common stock by mail, telephone, facsimile, telegraph or personal interviews and may request brokers, dealers and other nominee stockholders to forward materials to beneficial owners of shares of Pathmark common stock. Mellon Investor Services LLC will receive reasonable and customary compensation for its services (estimated at $5,000) and will be reimbursed for certain reasonable out-of-pocket expenses and other customary costs.
Adjournments
Although it is not expected, the Pathmark special meeting may be adjourned or postponed for the purpose of soliciting additional proxies or for any other reason. Any adjournment or postponement may be made without notice, other than by an announcement made at the Pathmark special meeting, by approval of the holders of a majority of the shares of Pathmark common stock present in person or represented by proxy at the special meeting. Any signed proxies received by Pathmark which are otherwise silent on the matter will be voted in favor of the proposal to adjourn or postpone the special meeting, if necessary, to solicit additional proxies. Any adjournment of the Pathmark special meeting for the purpose of soliciting additional proxies will allow Pathmark stockholders who have already sent in their proxies to revoke them at any time prior to their use.
Share Ownership of Management and Certain Stockholders
At the close of business on the record date, the directors and executive officers of Pathmark owned, in the aggregate, [ ] shares of Pathmark common stock, representing approximately [ ]% of the outstanding shares of Pathmark common stock entitled to vote (approximately [ ]% if the shares held by the Yucaipa Investors are excluded). The directors and executive officers have informed Pathmark that they intend to vote all of their shares of Pathmark common stock “FOR” the proposal to approve and adopt the merger agreement and the transactions contemplated thereby, including the merger.
At the close of business on the record date, the Yucaipa Investors beneficially owned [ ] shares of Pathmark common stock (excluding shares of Pathmark common stock issuable upon the exercise of warrants owned by the Yucaipa Investors to purchase shares of Pathmark common stock). The Yucaipa Investors have entered into a voting agreement with A&P pursuant to which the Yucaipa Investors have agreed to vote shares of Pathmark common stock that they own as of the Pathmark record date in favor of adoption of the merger agreement and the transactions contemplated thereby, provided that these voting obligations do not apply to any other shares owned by the Yucaipa Investors in excess of 33% of the outstanding Pathmark common stock. The remaining shares owned by the Yucaipa Investors may be voted in the Yucaipa Investors’ discretion, although the Yucaipa Investors have expressed their present intention to vote all of the Pathmark shares they own (approximately 38% of the outstanding Pathmark common stock) in favor of the adoption of
38
| S-4/A | 49th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 49th |
|---|
the merger agreement. See “Adoption of the Merger Agreement (Pathmark Proposal 1)—The Merger—Interests of Certain Persons in the Merger.”
Assistance
If you need assistance in completing your proxy card or have questions regarding the Pathmark special meeting, please contact:
|
|
|
|
Pathmark Stores, Inc. |
|
|
|
or |
|
|
|
Mellon Investor Services
|
39
| S-4/A | 50th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 50th |
|---|
ADOPTION OF THE MERGER AGREEMENT (PATHMARK PROPOSAL 1)
On March 4, 2007, the Pathmark board of directors and the A&P board of directors each authorized and declared the advisability of the merger agreement, which provides for the acquisition by A&P of Pathmark through a merger of Merger Sub, a newly formed and wholly owned subsidiary of A&P, with and into Pathmark. After the merger, Pathmark will be the surviving corporation and will be a wholly owned subsidiary of A&P.
Upon completion of the merger, each share of Pathmark common stock (other than dissenting shares) will be converted into the right to receive (i) 0.12963 of a share of A&P common stock, par value $1.00 per share, and (ii) $9.00 in cash, without interest.
In May 2004, Pathmark announced its preliminary first quarter results and revised downwards its earnings guidance for 2004. The first quarter results had been negatively affected by sales and gross profit pressures caused by steep inflation in certain product categories, unproductive sales promotions and increases in medical costs. Following this announcement, Pathmark’s share price fell approximately 19% to close at $6.91 on May 13, 2004. In light of these developments, Pathmark’s board of directors determined that it should explore strategic alternatives for the company. During the remainder of 2004, Pathmark undertook a review of strategic alternatives, focusing in particular on a sale of Pathmark to a strategic buyer or private equity firm. During the course of that process, Pathmark hired an investment banker, Dresdner Kleinwort Wasserstein (“DrKW”), which solicited over fifty potentially interested parties. The list of potentially interested parties, which was compiled by DrKW based upon its familiarity with the supermarket industry and further input from Pathmark’s board of directors and management team, was comprised of large strategic buyers, smaller strategic buyers with operations in geographic areas contiguous to those in which Pathmark operated, and financial buyers with a history of having made investments in the supermarket industry. DrKW was also retained to render a fairness opinion in the event that a sale of Pathmark was undertaken, and, as compensation for DrKW’s services relating to its fairness evaluation, Pathmark agreed, among other things, to pay DrKW a customary fee (which was payable on the date on which DrKW rendered its opinion), to reimburse DrKW for its reasonable out-of-pocket expenses related to its engagement and to indemnify DrKW and specified related persons against specific liabilities relating to or arising out of its engagement.
Throughout the lengthy strategic review process, Pathmark received from a number of parties various proposals and indications of interest regarding potential strategic transactions, including change of control transactions. The Yucaipa Investors were among those parties who initially submitted an indication of interest in November of 2004, although they were not among the parties that were contacted by DrKW and, accordingly, had not signed a confidentiality agreement or received a confidential information memorandum prepared by DrKW and circulated to other potentially interested third parties. After considering the merits of these indications of interest, the Pathmark board arranged for management presentations to be given to certain parties in late November and early December of 2004. The Yucaipa Investors did not participate in these presentations and indicated that they were not prepared to move forward at that time unless the Yucaipa Investors were granted exclusivity or were reimbursed for certain expenses. On December 2, 2004 Pathmark publicly announced that it had retained DrKW to aid in reviewing strategic alternatives, which could result in a decision to sell the company.
On December 20, 2004, three parties submitted letters indicating varying degrees of interest in moving forward with a strategic transaction, but none submitted a definitive proposal. Although, the Yucaipa Investors did not submit a proposal at this time, the Yucaipa Investors entered into a confidentiality agreement with Pathmark on January 7, 2005 and submitted a proposal letter to Pathmark on January 20, 2005, which was accompanied by a term sheet and form of exclusivity
40
| S-4/A | 51st "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 51st |
|---|
agreement. During the weeks that followed, Pathmark continued to engage in negotiations with multiple parties who had submitted proposals and indications of interest, including the Yucaipa Investors, and, on March 9, 2005, the Pathmark board commenced exclusive negotiations with the Yucaipa Investors after considering, among other things, (i) the fact that two other potentially- interested parties indicated that they were several weeks away from being ready to sign a definitive acquisition agreement, (ii) the price-level signaled by the Yucaipa Investors (which represented a significant increase from its initial indication of interest) and the fact that the Yucaipa Investors were refusing to move forward without exclusivity, (iii) the execution risks associated with the other possible transactions, including the risk that employee departures in reaction to a possible break-up of the business would make it difficult to maintain Pathmark’s business intact until closing; and (iv) the uncertainty of the financing needed to complete a number of the other remaining interested parties’ proposals.
After evaluating the various strategic alternatives available to Pathmark, the Pathmark board decided that the sale of a substantial minority interest to the Yucaipa Investors, in the form of common stock and Series A and B Warrants for $150 million in cash, was in the best interests of Pathmark and its stockholders and recommended its stockholders vote for the approval of the proposed transaction with the Yucaipa Investors. In the course of reaching its decision to approve the proposed transaction with the Yucaipa Investors, Pathmark’s board of directors considered numerous factors, including, among others, (i) the fact that the consideration was all cash, so that Pathmark would be able to reduce its leverage and immediately use the invested funds in furtherance of its capital expenditure plans with the goal of improving its operating performance; (ii) the fact that a substantial portion of the Yucaipa Investors’ upside was represented by the Series A and Series B Warrants giving the Yucaipa Investors an incentive to work to increase Pathmark’s value and thereby helping to align their interests with those of the remaining stockholders; (iii) the generally successful record of the Yucaipa Group’s investment performance; and (iv) the fact that Pathmark’s stockholders would have the ability to share in any upside that might result from any future improved performance on the part of Pathmark. On May 6, 2005, Pathmark disseminated to its stockholders a proxy statement for a special meeting describing in detail the Yucaipa Investors transaction, the background of the transaction and the board’s reasons for recommending the transaction. On June 9, 2005, the Pathmark stockholders approved the transaction with the Yucaipa Investors.
Pursuant to the Securities Purchase Agreement dated as of March 23, 2005 between Pathmark, the Yucaipa Investors and Yucaipa Companies (the “Yucaipa Purchase Agreement”), at the close of that transaction on June 9, 2005, Pathmark entered into the Stockholders Agreement with the Yucaipa Investors, which was subsequently amended and restated on August 23, 2005 and again on November 20, 2005, (the “Pathmark Stockholders Agreement”), relating to, among other matters, the governance of Pathmark after the closing, including the Yucaipa Investors’ ability to designate representatives on Pathmark’s board of directors, a requirement that Pathmark obtain written consent from the Yucaipa Investors prior to engaging in certain actions, and certain limitations on the Yucaipa Investors’ ability to purchase or sell Pathmark securities. Four current members of the Pathmark board of directors were designated by the Yucaipa Investors to serve on the Pathmark board pursuant to the Pathmark Stockholders Agreement. These directors are: Michael Duckworth and Ira Tochner—both of whom are representatives of Yucaipa Companies—and David Jessick, the current Chairman of the Pathmark board, and Gregory Mays. Mr. Jessick and Mr. Mays had each previously held posts in companies in which the Yucaipa Group had invested and have each been determined by the Pathmark board of directors to be independent under the NASDAQ Marketplace Rules.
Concurrently with the execution of the Yucaipa Purchase Agreement, Pathmark also entered into the Management Services Agreement with Yucaipa Companies pursuant to which Yucaipa Companies would provide, in exchange for the payment of management fees and the reimbursement of expenses, general business and management consultation and advice regarding strategic planning and development, budgeting, capital expenditure strategy, store development plans, labor strategy, financing plans, general business and economic matters and such other similar management services as requested by Pathmark’s board of directors or its chief executive officer.
41
| S-4/A | 52nd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 52nd |
|---|
Following the execution of the Yucaipa Purchase Agreement and the Management Services Agreement, Yucaipa Companies began exploration of strategic alternatives to enhance the value of the Yucaipa Investors’ investment in Pathmark, including consideration of acquisitions of other businesses, stock-for-stock mergers with other companies, and a sale of control of Pathmark. Ronald Burkle, the chairman of Yucaipa Companies with many years of supermarket industry knowledge and substantial experience in negotiating strategic transactions, led this review of alternatives.
Mr. Burkle contacted Christian Haub, Executive Chairman of the Board of A&P and Co-Chief Executive Officer of Tengelmann, the owner of 53% of A&P’s outstanding stock, as part of Yucaipa Companies’ review of its alternatives and of ways to maximize the value of the Yucaipa Investors’ investment in Pathmark. Mr. Burkle and Mr. Haub held several meetings during April, May and June of 2005 regarding a potential combination of Pathmark and A&P, including discussions regarding the potential benefits of a combination and operational synergies, as well as options for a pricing mechanism and exchange ratio that would be satisfactory to all parties. In addition, Mr. Burkle and Mr. Haub discussed the possibility of a merger of equals between A&P and Pathmark, the related options regarding pricing and governance, as well as A&P’s goals with respect to the sale of its Canadian operations. These preliminary discussions, however, did not result in any specific acquisition proposals and Mr. Burkle and Mr. Haub decided not to proceed with further discussions because, in part, they believed at that time that the public market valuations of the companies did not adequately reflect, in the case of Pathmark, the Yucaipa Investors’ purchase of a substantial minority interest in Pathmark, and in the case of A&P, the planned sale of its Canadian operations.
In August of 2005, John Standley was named by Pathmark to serve as its Chief Executive Officer and entered into an employment agreement with Pathmark pursuant to which he was retained to act in that capacity. Prior to his retention by Pathmark, Mr. Standley had held various executive posts in a number of companies engaged in the supermarket industry, including companies in which the Yucaipa Group had invested. Mr. Standley was also elected to the Pathmark board concurrently with his retention as Chief Executive Officer.
On October 25, 2005, the Pathmark board held a meeting at which the board discussed strategic alternatives for the company, including an acquisition of a supermarket chain with a significant number of stores in geographic areas that were contiguous to Pathmark’s operating areas (“Company A”), and a merger of Pathmark with A&P.
Following the Pathmark board meeting, Mr. Haub, Mr. Burkle, Mr. Duckworth and Cameron Reilly, a representative of Yucaipa Companies, and representatives of JPMorgan, as financial advisor to A&P, held a meeting in New York City, at which the parties discussed the possibility of a stock-for-stock business combination between A&P and Pathmark. The parties discussed potential arrangements for the governance and management of the combined entity and transfer and standstill restrictions on Tengelmann and the Yucaipa Investors as well as options for an exchange ratio and pricing mechanism, alternatives for an extraordinary cash dividend by A&P, the exercise or conversion of the Yucaipa Investors’ Series A and Series B Warrants and possible steps related to a “merger of equals.” Based on their discussion, Messrs. Haub and Burkle concluded that they could not reach common ground on a valuation that they could each recommend to their respective companies. Representatives of Yucaipa Companies also made preliminary inquiries regarding the acquisition of Company A; however, the pursuit of the acquisition was abandoned after Pathmark and Yucaipa Companies were informed that the owner of Company A had no interest in selling the stores in which Pathmark had expressed interest.
In early 2006, Mr. Burkle and Mr. Duckworth resumed discussions with Mr. Haub and Andreas Guldin, Co-Chief Financial Officer of Tengelmann, regarding a possible business combination of A&P and Pathmark. At the Pathmark board’s direction, Mr. Burkle and Mr. Duckworth assumed an active role in these discussions because of, among other things, their interest, as representatives of Pathmark’s largest stockholder, in ensuring that any transaction maximized stockholder value, the Yucaipa Group’s extensive experience in supermarket industry acquisitions and because any strategic transaction of this nature would require the Yucaipa Investors’ consent under the terms of the Pathmark Stockholders Agreement. In February 2006, Mr. Haub, Mr. Burkle, Mr. Duckworth and representatives of JPMorgan began discussions regarding a stock-for-stock merger of Pathmark and
42
| S-4/A | 53rd "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 53rd |
|---|
A&P, structured as a “merger of equals” in which each company’s stock would be valued based on then-current market prices, giving effect to an extraordinary cash dividend that A&P was otherwise planning to declare. Through an additional equity infusion, the Yucaipa Investors would have become significant stockholders of the combined company, with a stake approximately equal to that of Tengelmann, A&P’s largest stockholder. As a result, Tengelmann and the Yucaipa Investors together would have owned more than 50% of the combined company and would have entered into agreements regarding board representation and governance and other stockholder rights. Under the potential transaction, the Yucaipa Investors’ Series A Warrants would have been required by A&P to be exercised, but the exercise price would have been reduced in order to compensate the Yucaipa Investors for lost option value due to the forced early exercise. Under the potential transaction, the Series B Warrants would have been rolled over and exchanged for A&P warrants based on the transaction exchange ratio, which would have preserved the existing option value of the Series B Warrants.
At a regularly scheduled meeting of the Pathmark board of directors on March 13, 2006, Mr. Burkle advised the Pathmark board about the status of these discussions. In addition, Mr. Burkle advised the board that Yucaipa Companies had been approached by a third party regarding the possibility of Pathmark’s partnering with such party in a major strategic acquisition of another company, whose operations included a supermarket chain with locations throughout the northeastern United States (“Company B”). The board concluded that Yucaipa Companies should continue to explore both of these potential transactions.
During March 2006, Mr. Burkle, Mr. Duckworth, Mr. Haub, Mr. Guldin and representatives of JPMorgan and Latham & Watkins LLP, counsel to Pathmark (“Latham & Watkins”), had numerous meetings and phone calls regarding the potential merger of equals between Pathmark and A&P outlined above, including with respect to valuation, form of consideration, board representation and governance and other stockholder rights in respect of the combined company. Although the parties made progress on some issues, valuation and other substantial issues were not resolved, including the relative valuations of the two companies as well as transfer restrictions, corporate governance and social issues relating to the operation of the consolidated company. Accordingly, the parties ceased further discussions.
Shortly thereafter and for the next several weeks, Yucaipa Companies continued to analyze the possibility of Pathmark’s acquisition of Company B, as had been previously discussed with the Pathmark board on March 13, 2006. After a detailed review of valuation and multiple meetings with representatives of the third party that had expressed interest in partnering with Pathmark in the acquisition, Yucaipa Companies concluded that the potential third party partner and Pathmark would not be able to offer a sufficient premium price to make the proposal attractive to the owner of Company B.
In the summer of 2006, with rumors of a potential proposal by A&P to acquire Pathmark circulating publicly, Mr. Standley and Mr. Duckworth continued to review the possibility of a business combination between Pathmark and A&P, based on the strategic fit between the companies and the synergies that could be obtained. Since the earlier discussions involving a merger of equals between the two companies had not been successful and A&P did not make a proposal to acquire Pathmark, Mr. Standley and Mr. Duckworth began to explore the possibility of Pathmark acquiring A&P in a cash merger as part of their evaluation of available strategic alternatives for Pathmark. As part of this evaluation they developed a preliminary analysis of such a transaction for presentation to the Pathmark board at its next meeting.
Also during this period, Yucaipa Companies again had discussions with the owner of Company A regarding Pathmark acquiring a significant number of stores in contiguous markets as had previously been discussed at the October 25, 2005 Pathmark board meeting. Although these discussions proceeded further than they had in 2005, Yucaipa Companies ultimately determined that the owner of Company A planned to retain the stores in which Pathmark had expressed an interest and that further negotiations were unlikely to meet with any success.
On September 26, 2006, the Pathmark board of directors held a meeting at which Mr. Standley informed the board that he had been discussing with Yucaipa Companies the possibility of Pathmark
43
| S-4/A | 54th "Page" of 380 | TOC | 1st | Previous | Next | Bottom | Just 54th |
|---|
making a proposal to acquire A&P. Mr. Standley indicated that the companies would be a good strategic fit, and that there were substantial synergies to be obtained through elimination of duplicative administrative costs and efficiencies in the areas of distribution, transportation and marketing. Also, the combined companies would have increased economies of scale in purchasing. The board discussed some of the key issues in such a transaction. A&P had sold its Canadian operations and distributed a substantial portion of the sale consideration in the form of a special cash dividend to stockholders. A&P had significant liquid assets on its balance sheet, including a significant minority investment in Metro, the purchaser of A&P’s Canadian operations. The board also discussed Pathmark’s current market position, growth prospects, and liquidity needs within the next several years. The board acknowledged that, since Tengelmann held a majority of the stock of A&P, any transaction would require the support of Tengelmann. The board then authorized management and Yucaipa Companies to formulate a proposal for Pathmark to acquire A&P.
Following additional review and analysis by management and Yucaipa Companies, the Pathmark board held a special telephonic meeting on October 6, 2006. At this meeting, Mr. Standley and Frank Vitrano, the President and Chief Financial Officer of Pathmark, presented a proposed offer letter to acquire A&P and a “highly confident” letter from Citigroup for the debt financing for the acquisition, and Mr. Duckworth presented a draft $200 million equity commitment letter from Yucaipa Companies. Under this structure, the Series A and B Warrants would have remained in place. After discussion, the board authorized Mr. Standley to execute the proposed offer letter to A&P and instructed Mr. Burkle to deliver the proposal letter to A&P and to commence preliminary discussions regarding the proposed transaction.
Also at this meeting, the board noted the fact that Yucaipa Companies’ existing Management Services Agreement with Pathmark provides that, if the board decides in its discretion to engage Yucaipa Companies for merger consultation on a matter such as a business combination with A&P, the fee for such services would be 1% of the transaction value. The board discussed Yucaipa Companies’ extensive experience in supermarket industry acquisitions, Yucaipa Companies’ familiarity with A&P’s business based on its industry experience, and its deep knowledge of Pathmark’s operations and finances. The board members in attendance, with Mr. Duckworth abstaining, unanimously authorized the retention of Yucaipa Companies as a consultant on Pathmark’s acquisition of A&P, with the terms of the engagement to be subject to execution of a definitive engagement letter with Yucaipa Companies. Mr. Tochner was not in attendance at the meeting.
On October 9, 2006, Mr. Burkle and Mr. Duckworth had a meeting with Mr. Haub. They presented Mr. Haub with Pathmark’s confidential, nonbinding letter setting forth an offer to acquire all outstanding shares of A&P for a purchase price of $30.00 per share in cash. The letter included an equity commitment from Yucaipa Companies of up to $200 million, and a highly confident letter from Citigroup to raise the debt to finance the balance of the purchase price. Pathmark stated in the letter that it expected that the definitive acquisition agreement would not contain any financing condition. The letter indicated a two-week period for completion of confirmatory due diligence and stated that the proposal would expire on October 16, 2006.
At this meeting, Mr. Haub, speaking on behalf of Tengelmann, the majority stockholder of A&P, stated that Tengelmann would have no interest in the proposal. Mr. Haub also stated t